Amendments to Form 51-102F6 Statement of Executive Compensation and Consequential Amendments
Amendments to Form 51-102F6 Statement of Executive Compensation and Consequential Amendments
CSA NOTICE
AMENDMENTS TO FORM 51-102F6
STATEMENT OF EXECUTIVE COMPENSATION
AND
CONSEQUENTIAL AMENDMENTS
Introduction
We, the Canadian Securities Administrators (CSA), are adopting amendments to Form 51-102F6 Statement of Executive Compensation (the Form 51-102F6 Amendments).
The Form 51-102F6 Amendments will amend the previous version of Form 51-102F6 Statement of Executive Compensation (in respect of financial years ending on or after December 31, 2008) (Form 51-102F6), which came into effect in all CSA jurisdictions on December 31, 2008.
Concurrently with the Notice, we are publishing the amendment instruments for the Form 51-102F6 Amendments and the Consequential Amendments (as defined below), as well as a blackline of the Form 51-102F6 Amendments showing all changes from the versions currently in force. These documents are also available on the websites of CSA members, including the following:
• www.bcsc.bc.ca
• www.albertasecurities.com
• www.osc.gov.on.ca
• www.lautorite.qc.ca
• www.nbsc-cvmnb.ca
• www.gov.ns.ca/nssc
In some jurisdictions, Ministerial approvals are required for these changes. Subject to obtaining all necessary approvals, the Form 51-102F6 Amendments and Consequential Amendments (as defined below) will come into force on October 31, 2011.
Transition
The Form 51-102F6 Amendments will apply in respect of financial years ending on or after October 31, 2011. The Form 51-102F6 Amendments will also form part of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102), which sets out the obligations of reporting issuers, other than investment funds, for financial statements, management's discussion and analysis, annual information forms, information circulars and other continuous disclosure-related matters.
NI 51-102 refers and relies on references to Canadian generally accepted accounting principles (Canadian GAAP), which are established by the Canadian Accounting Standards Board (AcSB). The AcSB has incorporated International Financial Reporting Standards (IFRS), as adopted by the International Accounting Standards Board (IASB), into the Handbook of the Canadian Institute of Chartered Accountants (the Handbook) for most Canadian publicly accountable enterprises for financial years beginning on or after January 1, 2011. As result, the Handbook contains two sets of standards for public companies:
• Part I of the Handbook -- Canadian GAAP for publicly accountable enterprises that applies for financial years beginning on or after January 1, 2011, and
• Part V of the Handbook -- Canadian GAAP for public enterprises that is the pre-changeover accounting standards (2010 Canadian GAAP).
After the IFRS changeover date on January 1, 2011, non-calendar year-end issuers will continue to prepare financial statements in accordance with 2010 Canadian GAAP until the start of their new financial year.
To further assist issuers and their advisors and increase transparency, during the transition period, certain jurisdictions will post two different unofficial consolidations of NI 51-102 that will include the Form 51-102F6 Amendments on their websites:
• the version of NI 51-102 that contains 2010 Canadian GAAP terms and phrases, which apply to reporting issuers in respect of documents required to be prepared, filed, delivered or sent under the rules for periods relating to financial years beginning before January 1, 2011; and
• the new version of NI 51-102 that contains IFRS terms and phrases, which apply to reporting issuers in respect of documents required to be prepared, filed, delivered or sent under the rules for periods relating to financial years beginning on or after January 1, 2011.
Substance and Purpose of the Form 51-102F6 Amendments
On September 18, 2008, we announced the adoption of Form 51-102F6, which became effective across all CSA jurisdictions on December 31, 2008. In adopting Form 51-102F6, the CSA's stated intention was to create a document that would continue to provide a suitable framework for disclosure as compensation practices change over time.
On November 20, 2009, CSA Staff Notice 51-331 Report on Staff's Review of Executive Compensation Disclosure (the Staff Notice) was issued and reported the findings of a targeted compliance review of executive compensation disclosure. 70 reporting issuers were selected for this review. Staff of the British Columbia Securities Commission, the Alberta Securities Commission, the Ontario Securities Commission and the Autorité des marchés financiers participated in the targeted compliance reviews.
The focus of the reviews was to:
(i) assess compliance with Form 51-102F6,
(ii) use the review results to educate companies about the new requirements, and
(iii) identify any requirements that need clarification or further explanation to assist companies in fulfilling their disclosure obligations.
We asked most of the companies reviewed to improve their disclosure in future filings in respect of the disclosure issues that were identified in the targeted reviews and discussed in the Staff Notice.
In addition, we have seen a number of recent international developments in the area of executive compensation. In particular, on December 16, 2009, the Securities and Exchange Commission (SEC) adopted rules amending compensation and corporate governance disclosure requirements for U.S. companies in the 2010 proxy season (the 2010 SEC Amendments). In addition, on July 15, 2010, the United States Congress passed a final version of the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act), which came in force for the 2011 proxy disclosures.
We reviewed the issues discussed in the Staff Notice and the amendments in the 2010 SEC Amendments and the Dodd-Frank Act that we thought are also relevant to Canadian reporting issuers. As a result, we developed proposed amendments to Form 51-102F6 to improve the information companies provide investors about key risks, governance and compensation matters. The Form 51-102F6 Amendments were published for a 90-day comment period on November 19, 2010 (the November 2010 Materials).
The Form 51-102F6 Amendments, which range from drafting changes to clarify existing disclosure requirements to new substantive requirements, reflects our further consideration of these proposed amendments in light of the comments we received. We think the Form 51-102F6 Amendments will help investors make more informed voting and investment decisions and will enhance the quality of information provided to investors and assist companies in fulfilling their executive compensation disclosure obligations.
Written Comments
The comment period expired on February 17, 2011. During the comment period we received submissions from 28 commenters. We have considered these comments and we thank all the commenters. A list of the 28 commenters and a summary of their comments, together with our responses, are contained in Appendices B and C.
Summary of Changes to the November 2010 Materials
We have made some revisions to the November 2010 Materials, including drafting changes made only for the purposes of clarification or in response to comments received. Appendix A describes the key changes made to the November 2010 Materials. As the changes are not material, we are not republishing the Form 51-102F6 Amendments for a further comment period. A blackline of the Form 51-102F6 Amendments showing all changes from the version currently in force is included in Appendix G.
Consequential Amendments
We are also adopting related consequential amendments to the following:
• Sections 9.3.1 and 11.6 of NI 51-102,
• Form 58-101F1 Corporate Governance Disclosure (Form 58-101F1), and
• Form 58-101F2 Corporate Governance Disclosure (Venture Issuers) (Form 58-101F2) of National Instrument 58-101 Disclosure of Corporate Governance Practices (NI 58-101).
(together, the Consequential Amendments).
The Consequential Amendments are contained in Appendix E.
Local Notices
Certain jurisdictions are publishing other information required by local securities legislation in Appendix F.
Questions
If you have any questions, please refer them to any of the following:
British Columbia Securities Commission
|
|
Jody-Ann Edman
|
|
Senior Securities Analyst, Corporate Finance
|
|
Phone: 604-899-6698
|
|
E-mail: [email protected]
|
|
|
|
Alberta Securities Commission
|
|
Cheryl McGillivray
|
Anne Marie Landry
|
Manager, Corporate Finance
|
Securities Analyst
|
Phone: 403-297-3307
|
Phone: 403-297-7907
|
E-mail: <<[email protected]>>
|
E-mail: <<[email protected]>>
|
|
|
Ontario Securities Commission
|
|
Sonny Randhawa
|
Christine Krikorian
|
Assistant Manager, Corporate Finance
|
Accountant, Corporate Finance
|
Phone: 416-204-4959
|
Phone: 416-593-2313
|
E-mail: <<[email protected]>>
|
E-mail: <<[email protected]>>
|
|
|
Frédéric Duguay
|
|
Legal Counsel, Corporate Finance
|
|
Phone: 416-593-3677
|
|
Email: <<[email protected]>>
|
|
|
|
Autorité des marches financiers
|
|
Lucie J. Roy
|
Pasquale Di Biasio
|
Senior Policy Advisor
|
Analyst
|
Service de la réglementation
|
Service de l'information continue
|
Phone: 514-395-0337, ext 4464
|
Phone: 514-395-0337, ext 4385
|
E-mail: <<[email protected]>>
|
E-mail: <<[email protected]>>
|
|
|
New Brunswick Securities Commission
|
|
Pierre Thibodeau
|
|
Senior Securities Analyst
|
|
Phone: 506-643-7751
|
|
E-mail: <<[email protected]>>
|
|
|
|
Nova Scotia Securities Commission
|
|
Junjie (Jack) Jiang
|
|
Securities Analyst, Corporate Finance
|
|
Phone: 902-424-7059
|
|
E-mail: <<[email protected]>>
|
July 22, 2011
APPENDIX A
SUMMARY OF KEY CHANGES TO THE NOVEMBER 2010 MATERIALS
Form 51-120F6 Amendments
Item 1 - General Provisions
Subsection 1.3(9) -- Currencies
• We amended subsection 1.3(9) to provide flexibility if the company's performance goals and similar conditions disclosed in the Compensation Discussion and Analysis are in a currency different than the currency presented in the prescribed tables, which may be for purposes of consistency with financial reporting obligations. As a result, a company must use the same currency in the tables prescribed in sections 3.1, 4.1, 4.2, 5.1, 5.2 and 7.1 of the form.
Item 2 -- Compensation Discussion and Analysis (CD&A)
Subsection 2.1(5) -- Risks associated with the company's compensation policies and practices
• We amended subsection 2.1(5) to include the words "or a committee of the board" in order to recognize that compensation-related duties may be delegated to a committee of the board.
Commentary
• We revised the commentary to clarify that, if the company used any benchmarking in determining compensation or any element of compensation, the company should include the benchmark and describe why the benchmark group and selection criteria are considered by the company to be relevant.
• We added commentary to the examples of situations that could potentially encourage an executive officer to expose the company to inappropriate or excessive risks by including the example of incentive plan awards that do not provide a maximum benefit or payout limit to executive officers.
• We also added commentary to clarify that the examples of situations that could potentially encourage an executive officer to expose the company to inappropriate or excessive risks are not exhaustive and the situations to consider will vary depending upon the nature of the company's business and the company's compensation policies and practices.
Section 2.4 -- Compensation Governance
• We amended paragraph 2.4(2)(a) to read:
• Disclose the name of each committee member and, in respect of each member, state whether or not the member is independent or not independent.
• In paragraph 2.4(2)(c), we removed the words "that are consistent with a reasonable assessment of the company's risk profile" because we concluded that the words were unnecessary and confusing.
• We amended paragraph 2.4(3)(c) to read:
• If the consultant or advisor has provided any services to the company, or to its affiliated or subsidiary entities, or to any of its directors or members of management, other than or in addition to compensation services provided for any of the company's directors or executive officers,
(i) state this fact and briefly describe the nature of the work,
(ii) disclose whether the board of directors or compensation committee must pre-approve other services the consultant or advisor, or any of its affiliates, provides to the company at the request of management.
• In subparagraphs 2.4(3)(d)(i) and (ii), we added the word "each" to clarify that the company must disclose aggregate fees paid on a "per consultant" basis.
Item 4 -- Incentive Plan Awards
Section 4.1 -- Outstanding share-based awards and option-based awards
• We amended subsection 4.1(3) to clarify that if the company has granted options in a different currency than that reported in the table, the company must include a footnote describing the currency and the exercise or base price. This amendment is also made in response to the requirement in subsection 1.3(9) that the company must use the same currency in the prescribed tables of the form.
Item 5 -- Pension Plan Benefits
Section 5.1 - Defined benefit plans table
• We amended paragraph 5.1(4)(a) to include the requirement that, for purposes of calculating the annual lifetime benefit payable at the end of the most recently completed financial year in column (c1), the company must assume that the NEO is eligible to receive payments or benefits at year end.
• We added commentary to clarify that the company may calculate the annual lifetime benefit payable in accordance with the formula included as commentary or in accordance with another formula if the company reasonably believes that the other formula produces a more meaningful calculation of the annual lifetime benefit payable at year end.
Section 5.2 -- Defined contribution plans table
• In response to questions 6 and 7 published in the notice to the November 2010 Materials and comments received, we removed the requirement in subsection 5.2(3) to disclose the non-compensatory amount, including employee contributions and regular investment earnings on employer and employee contributions.
APPENDIX B
LIST OF COMMENTERS
We received 28 comment letters in response to the request for comment. We thank the commenters for their comments.
1. Astral Media Inc.
2. BC Investment Management Corporation
3. Blake, Cassels & Graydon LLP
4. Bombardier Inc.
5. Canadian Bankers Association
6. Canadian Coalition for Good Governance
7. Canadian Society of Corporate Secretaries
8. CGI Group Inc.
9. Chris Reed (Investor)
10. Edwin A. Simmons (Investor)
11. H. Garfield Emerson
12. Hugessen Consulting Inc.
13. Institutional Shareholder Services
14. Loblaw Companies Limited
15. Mercer (Canada) Limited
16. Metro Inc.
17. Mouvement d'éducation et de défense des actionnaires
18. NEI Investments
19. Ogilvy Renault LLP
20. Ontario Teachers' Pension Plan
21. Pension Investment Association of Canada
22. Praemis Consulting
23. Regroupement Independent des Conseillers de l'Industrie Financière du Québec
24. Robert Gatto (Investor)
25. Shareholder Association for Research & Education
26. Social Investment Organization
27. Towers Watson Canada Inc.
28. WestJet Airlines Ltd.
The comment letters are available at www.osc.gov.on.ca.
In the following summary, we refer to the authors of a comment letter as "the commenter" regardless of the number of authors.
APPENDIX C
SUMMARY OF COMMENTS AND CSA RESPONSES
ITEM |
COMMENTS |
CSA RESPONSES |
||||
|
||||||
GENERAL COMMENTS |
||||||
|
||||||
0.1 |
Generally, 17 commenters supported the proposed amendments and believed they will improve the quality of executive compensation disclosure and help investors make more informed voting and investment decisions. |
We thank the commenters for their support. |
||||
|
||||||
0.2 |
Three commenters did not believe that the proposed amendments were needed at this time, given that the new executive compensation disclosure requirements have only been in place for two years, and questioned whether further changes were appropriate at this time. |
As part of the rulemaking process, we closely monitor new rules in the first year after implementation to ensure that they are working as intended and we may consider additional communication or additional amendments to address any issues that arise as a result of this monitoring process. As stated in the Notice, the November 2010 Materials were published after reviewing, among others, the issues discussed in CSA Staff Notice 51-331 Report on Staff's Review of Executive Compensation Disclosure (CSA Staff Notice 51-331), published on November 20, 2009. |
||||
|
||||||
0.3 |
One commenter noted that, since most investors now participate in the capital markets indirectly through managed funds of one type or another, securities regulators should focus on how compensation structures function for fund managers, and particularly whether their compensation aligns their interests with those of the investors for whom they act, namely whether their compensation is appropriately linked to their performance in creating value for investors. |
We thank the commenter for the comment. Reviewing the compensation policies and practices for investment fund managers is beyond the scope of this initiative. We have forwarded this comment to the CSA committee responsible for National Instrument 81-106 Investment Fund Continuous Disclosure. |
||||
|
||||||
0.4 |
Commenters support the CSA efforts to harmonize, where possible, the proposed amendments with the executive compensation disclosure requirements in the United States, given the number of companies in Canada that are also listed on U.S. stock exchanges. |
We thank the commenters for their support. Our goal is to develop effective executive compensation disclosure rules in Canada. Though we have reviewed the provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the latest amendments made by Securities and Exchange Commission that we think are also relevant to Canadian reporting issuers, we have made some departures that we think are appropriate for our Canadian markets. |
||||
|
||||||
ITEM 1 -- GENERAL PROVISIONS |
||||||
|
||||||
1.1 |
Section 1.1 - Objective |
|
||||
|
||||||
|
Commenters asked that we clarify why the language in the objective section (and the corresponding commentary following subsection 3.1(5)) has been revised. |
We have not amended the Form in response to these comments. Subsection 3.1(3) and (4) of the Form requires companies to disclose the fair value of the award on the grant date for share-based awards and option-based awards in the appropriate columns in the Summary Compensation Table (SCT). Under these requirements, the fair value of the award on the grant date for these types of awards must be reported in the SCT in the year of grant irrespective of whether part or all of the award relates to multiple financial years and payout is subject to performance goals and similar conditions, including vesting, to be applied in future financial years. We also clarified this requirement in CSA Staff Notice 51-331. |
||||
|
||||||
|
In addition, five commenters suggest that the proposed amendment should not be made. In particular, the commenters do not support the amendments made to the requirements in section 3.1 relating to the board's intended annual compensation for option-based awards, because they find the current wording to be more in line with the board's decisions and they think that the proposed amendment will be detrimental to appropriate and meaningful disclosure. |
|
|
|
||
|
||||||
1.2 |
Section 1.2 -- definition "named executive officer" (NEO) |
|
|
|
||
|
||||||
|
Six commenters suggest the words "including any of its subsidiaries" should be revised to clarify that only executive officers that have policy-making functions at the issuer level should be considered as NEOs of the issuer. The commenters believe that executive officers of subsidiaries should not be considered NEOs of the parent company unless they perform a policy-making function with respect to the parent company. |
We agree and we do not think that an amendment to the definition of "NEO" is necessary to address this comment. Under the paragraph (c) of the definition of "executive officer" in section 1.1 NI 51-102, a director, an officer, or another employee of a subsidiary of a company is an executive officer of the company if that individual performs a policy-making function in respect of the company. Such an individual would also be an NEO for the purposes of the Form if the individual otherwise satisfies the criteria set out in the definition of "NEO". |
||||
|
||||||
|
One commenter suggests that we amend the definition of "executive officer" in section 1.1 of National Instrument 51-102 Continuous Disclosure Obligations (NI 51-102). In particular the reference to "vice president in charge" should be amended to "executive" in charge to capture presidents of principal business units or subsidiaries. |
We acknowledge the comment and we do not propose to amend the definition of "executive officer" to address this comment. We have forwarded this comment to the CSA committee responsible for NI 51-102 for further consideration. |
||||
|
||||||
|
One commenter suggests that, given the prevalence of reporting issuers which are in turn subsidiaries of other reporting issuers, there should be an exemption, in either the definition of NEO, or in the Form disclosure requirements, for disclosure of executive officers of subsidiaries which themselves are reporting issuers. The commenter argues that, in such circumstances, the CD&A of the parent company would only provide a reference to the disclosure of the public subsidiary and would provide "double counting" of the same disclosure. |
We have not made the suggested change. The Form requires disclosure for each CEO and CFO, regardless of their compensation and each of three most highly compensated executive officers whose total compensation is greater than $150,000. Under this definition, an executive officer who otherwise satisfies the definition of "NEO" for the parent company will be an NEO, even if the same individual is also an NEO for the subsidiary. We do not agree that this requirement would result in "double counting" of the same disclosure. The CD&A requires a discussion and analysis of the executive compensation provided to NEOs of the company. In certain circumstances, companies will be required to disclose information about how their compensation policies and decisions apply to an NEO who is also an NEO of a subsidiary or an NEO of the parent. |
||||
|
||||||
1.3 |
Subsection 1.3(2) -- Departures from format |
|
|
|
||
|
||||||
|
Six commenters support the proposed requirement to clarify that a company may not alter the presentation of the SCT by adding columns or other information and agree that a common format for the SCT creates consistency in reporting. |
We thank the commenters for their support. As explained in Staff Notice 51-331, the SCT provides a comprehensive overview of a company's executive compensation policies and practices in a consistent and meaningful way. We have amended subsection 1.3(2) to clarify that companies may choose to add another table and other information, so long as the additional information does not detract from the SCT prescribed in subsection 3.1(1). |
||||
|
||||||
|
Conversely, four commenters did not support the proposed amendment and recommended that we remove the prohibition on altering the presentation of the SCT. |
In light of our response above, we have not amended the Form in response to this comment. |
||||
|
||||||
|
One commenter suggests that the proposed requirement to not alter the format of the SCT should be extended to all prescribed tables under the Form. |
We have not amended the Form in response to this comment. We think that the SCT serves as the principal disclosure vehicle for executive compensation and applies to all companies. On the other hand, we think that the other prescribed tables in the Form will not necessarily apply to all companies. |
||||
|
||||||
|
Two commenters suggest that we amend the proposed requirement to permit the addition of a "total direct compensation" column before the "pension benefits" column of the SCT. |
We have not amended the Form in response to this comment. We reiterate that subsection 1.3(2) allows a company to provide additional tables and information in the Form, as a supplement to the SCT, if necessary to achieve the objective of executive compensation disclosure in section 1.1 of the Form. |
||||
|
||||||
1.4 |
Subsection 1.3(9) -- Currencies |
|
|
|
||
|
||||||
|
Two commenters believe the requirement to use a single currency throughout the Form may be too stringent and misleading to investors, as it may be interpreted as prohibiting issuers to disclose factual information in foreign currency in the CD&A where this information is necessary to understand the compensation decisions made by the board of directors. For example, stock options for which the exercise price is set in a different currency should not be converted to Canadian dollars. |
We have amended subsection 1.3(9) in response to these comments. We acknowledge that a company's performance goals and similar conditions disclosed in the CD&A may be in a currency different than the currency presented in the tables, which may be for purposes of consistency with financial reporting obligations. |
||||
|
||||||
|
In addition, one commenter suggests that the requirement to use a single currency apply to all the tables prescribed by the Form, and to the quantification of termination and change of control payments and benefits, but companies be allowed to use the currency or currencies in the CD&A that they believe are the most appropriate to use when explaining their compensation decisions for the year to their investors. |
We have amended the first paragraph in subsection 1.3(9) of the Form to read: |
||||
|
||||||
|
Two commenters ask that we clarify the preferred approach to report individual option-based awards disclosed in the outstanding share-based awards and option-based awards table that have been granted with an exercise price in a different currency than reported in the SCT. |
"A company must report amounts required by this form in Canadian dollars or in the same currency that the company uses for its financial statements. A company must use the same currency in the tables prescribed in sections 3.1, 4.1, 4.2, 5.1, 5.2 and 7.1 of this form." |
||||
|
||||||
|
|
|
We have amended subsection 4.1(3) of the Form to read: |
|||
|
|
|
"If the option was granted in a different currency than that reported in the table, include a footnote describing the currency and the exercise or base price." |
|||
|
||||||
1.5 |
Subsection 1.3(10) - Plain Language |
|
|
|
||
|
||||||
|
Five commenters believe that the requirement to explain "how specific NEO and director compensation relates to the overall stewardship and governance of the company" is unclear and confusing and that the words "overall stewardship and governance of the company" seem to tie compensation disclosure with board and NEO fiduciary duties. |
We acknowledge the comment and disagree. We have not amended the Form as we think the words "how specific NEO and director compensation relates to the overall stewardship and governance of the company" are tied to the overall objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
|
One commenter suggests that the requirement be amended to provide that companies should be disclosing how their executive compensation policies and procedures incentivize management to achieve their companies' stated objectives, overall strategy and risk management objectives. |
In light of our response above, we have not amended the Form in response to this comment. |
||||
|
||||||
ITEM 2 -- COMPENSATION DISCUSSION & ANALYSIS (CD&A) |
||||||
|
||||||
2.1 |
Section 2.1 - CD&A (materiality) |
|
|
|
||
|
||||||
|
One commenter suggests that we amend subsection 2.1(1) by inserting the words "material aspect of" following the word "include" and preceding the words "the following" so that there is an element of materiality added to the requirements for CD&A disclosure. |
We continue to think that companies must determine which of their compensation policies and practices are significant and disclose these policies and practices if necessary to satisfy the objective set out in section 1.1 of the Form. |
||||
|
||||||
2.2 |
Section 2.1 -- CD&A (additional commentary) |
|
|
|
||
|
||||||
|
Five commenters did not support the additional commentary asking the company to consider whether the company will be making any significant changes to its compensation policies and practices in the next financial year and disclose the changes. They argued that this proposed disclosure requirement would force companies to speculate about whether any significant compensation changes may take place in the future. |
We disagree. The additional commentary after section 2.1 of the Form is provided as an example of disclosure concerning compensation and is not intended to be a prescribed requirement. We note that a company would only be required to discuss whether the company will be making significant changes to its compensation policies and practices in circumstances where the company has committed to any such changes. The additional commentary is not asking companies to speculate about whether any compensation changes may take place in the future. |
||||
|
||||||
2.3 |
Subsection 2.1(3) -- Benchmarking |
|
|
|
||
|
||||||
|
Five commenters suggest that we expand the benchmarking requirement to require companies to explain why the benchmark group and criteria chosen is considered by the company to be relevant or, if the company does not benchmark, explain the rationale for not using any benchmark peer group. |
In CSA Staff Notice 51-331, we reported that a number of companies did not clearly explain their benchmarking methodologies and did not fully explain how they used that information in decisions about executive compensation. We have included additional commentary to section 2.1 of the Form to read: |
||||
|
||||||
|
|
|
"3. If the company used any benchmarking in determining compensation or any element of compensation, include the benchmark group and describe why the benchmark group and selection criteria are considered by the company to be relevant." |
|||
|
||||||
|
|
|
We have not amended the Form to require companies who do not benchmark to explain the rationale for not using any benchmark peer group. We think the Form does not require companies to disclose information relating to executive compensation practices that do not apply to a company's particular circumstances. |
|||
|
||||||
2.4 |
Subsection 2.1(4) -- Performance goals or similar conditions (serious prejudice exemption) - support |
|
|
|
||
|
||||||
|
Ten commenters agree that a company should be required to explicitly state that it is relying on the serious prejudice exemption and explain why disclosing the relevant performance goals or similar conditions would seriously prejudice the company's interests. |
We thank the commenters for their comments. |
||||
|
||||||
|
The commenters made the following additional comments in support of the proposed amendment: |
|
|
|
||
|
||||||
|
• |
Companies have previously relied on the serious prejudice exemption without sufficient justification, even when the relevant information was previously disclosed in other publicly filed documents. |
|
|
|
|
|
||||||
|
• |
The statement that the disclosure of broad corporate-level financial performance metrics will not in itself be considered by the CSA to result in 'serious prejudice' is a useful clarification to the disclosure requirements. |
|
|
|
|
|
||||||
|
• |
The proposed amendment will assist companies in formulating and articulating their use of the serious prejudice exemption. |
|
|
|
|
|
||||||
|
One commenter believes that a company should only be able to avail itself of the serious prejudice exemption if it has previously applied and received written authorization from the securities regulatory authority following pre-established criteria. This exemptive relief application should also be disclosed in the CD&A. |
We have not amended the Form in response to this comment. We note that we have an ongoing commitment to conduct normal course continuous disclosure reviews. These reviews typically include consideration of a company's executive compensation disclosure, including the disclosure of performance goals or similar conditions and the company's reliance on the "serious prejudice" exemption. Though we do not generally disclose the results of individual reviews, we may publish additional guidance in the form of a staff notice if we find recurring deficiencies or themes in the disclosure that we believe will be of interest to other companies. |
||||
|
||||||
2.5 |
Subsection 2.1(4) -- Performance goals or similar conditions (serious prejudice exemption) -- no support |
|
|
|
||
|
||||||
|
Nine commenters did not support the proposed amendment limiting the use of the serious prejudice exemption and are concerned with the proposed language to the effect that a company's interests should not be considered to be seriously prejudiced solely by disclosing performance goals or similar conditions if those goals or conditions are based on broad corporate-level financial performance metrics, such as earnings per share, revenue growth and earnings before interest, taxes, depreciation and amortization (EBITDA). The commenters asked that we reconsider our approach and remove this proposed amendment. |
We disagree and we have not amended the Form in response to these comments. Subsection 2.1(1) of the Form requires a company to discuss how it determined compensation amounts for each significant element of executive compensation. This disclosure requirement includes any performance goals or similar conditions that are based on objective, identifiable measures, such as the company's share price or earnings per share. We do not think that we have narrowed the circumstances upon which a company may rely on the "serious prejudice" exemption in subsection 2.1(4) of the Form. In CSA Staff Notice 51-331, we stated that disclosing performance metrics based on broad corporate-level financial performance measures like EPS, revenue growth and EBITDA, would not seriously prejudice the company's interests. In addition, these measures are generally publicly available in other disclosure documents or can be easily derived and calculated from the company's public disclosure. Companies that do not disclose specific performance goals must also state what percentage of the NEO's total compensation relates to the undisclosed information and how difficult it would be for the NEO, or how likely it would be for the company, to achieve the undisclosed performance goal. |
||||
|
||||||
|
The commenters made the following additional comments: |
We continue to think that this exemption strikes an appropriate balance between the interests of companies and investors. The "serious prejudice" exemption only applies to target levels concerning specific quantitative and qualitative performance related factors or criteria that would seriously prejudice the company's interests. Thus, even if the disclosure of a target level itself may seriously prejudice the company's interests in a particular case, disclosure of the metric itself would typically not. We also note that this exemption does not apply if a performance target level or other factor or criteria has been publicly disclosed. |
||||
|
||||||
|
• |
Requiring companies to state the basis on which they are not providing certain disclosure is anomalous in securities legislation, as companies generally are not required to disclose when they are not disclosing something on the basis the requirements do not require disclosure. |
|
|
|
|
|
||||||
|
• |
There is a fundamental difference between disclosing general financial information and financial targets used for setting compensation. For example, financial targets used in making compensation decisions are frequently subject to exceptions and are not in accordance with Canadian GAAP or IFRS. |
|
|
|
|
|
||||||
|
• |
Performance goals or similar conditions used for compensation are often based on the results of an NEO's business unit, division or subsidiary. |
|
|
|
|
|
||||||
|
• |
Disclosure of this information could provide a company's competitors with insight into its confidential business plans and strategies by allowing competitors to compare performance goals or similar conditions against the company's publicly disclosed results and identify the factors and underlying assumptions that are reflected in the company's confidential business plans. |
|
|
|
|
|
||||||
|
• |
Disclosure of this information could provide valuable information to competitors seeking to solicit the company's executive officers and could result in upward pressure on companies to increase the compensation of their executive officers. |
|
|
|
|
|
||||||
|
• |
Aggressive performance goals (i.e. "stretch targets") designed to encourage executive performance are often very sensitive and subjective information. In most cases, they should not be disclosed, even on a historical basis. |
|
|
|
|
|
||||||
|
• |
Disclosure of forward-looking performance goals or similar conditions may inadvertently and indirectly provide future oriented financial information (FOFI). |
|
|
|
|
|
||||||
2.6 |
Subsection 2.1(4) - Performance goals or similar conditions (additional disclosure requirements) |
|
|
|
||
|
||||||
|
Two commenters suggest that subsection 2.1(4) should include a requirement for companies to specifically explain why certain performance metrics were chosen and how these metrics align with the company's strategic plan and long-term priorities. |
We thank the commenters for their comments. At this time, we do not think additional amendments to the Form are necessary. We note that such disclosure may be required to be included in the CD&A under subsection 2.1(1) of the Form where it is necessary to describe or explain the objectives of any compensation program or strategy, or how each element of compensation and the company's decisions about that element fit into the company's overall compensation objectives and affect decisions about other elements. In CSA Staff Notice 51-331, we also noted that companies who applied discretion to either increase or decrease compensation following the initial setting of performance goals or similar conditions must fully explain the discretionary process in their CD&A in order to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
|
In addition, two commenters suggest that subsection 2.1(4) should include a requirement for companies to explain, in the absence of specific performance goals or similar conditions for NEOs, how the company has historically implemented a robust pay-for-performance structure in recently completed financial years and whether discretion is used by the board of directors with respect to payouts. |
|
|
|
||
|
||||||
2.7 |
Subsection 2.1(4) - Performance goals and similar conditions (use of discretion by the board) |
|
|
|
||
|
||||||
|
Four commenters recommend that the new commentary asking the company to consider whether the board of directors can exercise discretion to award compensation during the most recently completed financial year should be elevated as a disclosure requirement. These commenters believe investors should be provided with information with respect to the extent, if any, that the board of directors or the compensation committee exercises discretion to award compensation where performance goals have not been met, or waives or changes performance goals to payout, or increases compensation beyond previously approved levels. |
We thank the commenters for their comments. At this time, we do not think that additional amendments to the Form are necessary. We note that such disclosure may be required to be included in the CD&A under subsection 2.1(1) of the Form to describe or explain the significant elements of compensation, including how the company determines the amount (and, where applicable, the formula) for each element of compensation. We also noted in CSA Staff Notice 51-331 that companies who applied discretion to either increase or decrease compensation following the initial setting of objective performance goals should have clarified in the CD&A that the objective measures were only intended to be guidelines and explained the importance of board discretion in determining the actual bonus paid to each NEO. |
||||
|
||||||
2.8 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (general) |
|
|
|
||
|
||||||
|
Ten commenters agree that expanding the scope of the CD&A to require disclosure concerning a company's compensation policies and practices as it relates to risk will provide meaningful disclosure and help investors make more informed voting and investment decisions. One commenter further believes that the proposed requirement is preferable to the approach taken by the SEC, which requires disclosure only if risks arising form compensation policies and practices are "reasonably likely to have a material adverse effect" on the company. |
We thank the commenters for their support. |
||||
|
||||||
|
However, two commenters are concerned that the proposed risk disclosure requirement will not provide meaningful information to investors and could result in boilerplate disclosure that may give investors a false sense of comfort regarding the company's compensation policies and practices as they relate to risk and risk-taking or over-emphasize the importance of compensation-related risks in a document where there is no other risk-related disclosure. |
We note that we have an ongoing commitment to conduct normal course continuous disclosure reviews. These reviews typically include consideration of a company's executive compensation disclosure, including the disclosure of risks related to compensation policies and practices. Though we do not generally disclose the results of individual reviews, we may publish additional guidance in the form of a staff notice if we find recurring deficiencies or themes in the disclosure that we believe will be of interest to other companies. |
||||
|
||||||
|
Five commenters think that the proposed risk disclosure requirement is not necessary and note that the current requirements relating to risk factor disclosure prescribed by Form 51-102F1 Management Discussion & Analysis (Form 51-102F1) and Form 51-102F2 Annual Information Form (Form 51-102F2) are broad enough to cover material risks, including those relating to compensation. As such, the compensation risks that are "reasonably likely to have a material effect on the company" should not be required to appear in the CD&A if they are not required to be listed in the Management Discussion & Analysis or the Annual Information Form. |
We acknowledge the comments. While certain risk disclosures are already required by the other Instruments noted (such as Form 51-102F1 and Form 51-102F2), we think that the disclosure of any material risks related to compensation policies and practices will provide investors with clearer and more meaningful executive compensation disclosure. We acknowledge that there may be duplication in some situations, however the disclosure requirements in the Form go beyond those prescribed by the other Instruments as a company is also required to disclose: (i) the nature and extent of the board's role in the risk oversight of compensation policies and practices; and (ii) any practices used to identify and mitigate compensation policies and practices that could encourage a named executive officer (NEO) or individual at a principal business unit or division to take inappropriate or excessive risks. |
||||
|
||||||
2.9 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (independent risk report) |
|
|
|
||
|
||||||
|
One commenter believes that the proposed disclosure requirement should be expanded to require the disclosure of a report from an independent risk management expert certifying the rigorousness of the practices used to identify and mitigate compensation policies and practices that could potentially encourage NEOs or individuals at a principal business unit or division to take inappropriate or excessive risks. |
We have not amended the Form in response to this comment. When proposing rule amendments, we must consider the costs of new regulation imposed on companies and whether those costs are justified by the likely outcomes. We do not think that the benefits of disclosing a report from an independent risk management expert certifying the company's risk management practices related to compensation policies and practices will outweigh the additional costs imposed to companies. |
||||
|
||||||
2.10 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (scope of risk analysis) |
|
|
|
||
|
||||||
|
One commenter recommends that the disclosure requirement be limited to NEOs to simplify the risk assessment and related disclosure obligation. |
We have not amended the Form in response to this comment. We think there may be risks related to compensation policies and practices for individuals beyond NEOs, including at a principal business unit of the company, which could have a material adverse effect on the company. |
||||
|
||||||
|
One commenter believes that a meaningful discussion of risk in the context of compensation should include individuals other than NEOs given that they may participate in activities that could present significant risks to the company. |
We agree with the commenter. |
||||
|
||||||
2.11 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (drafting suggestion) |
|
|
|
||
|
||||||
|
Five commenters suggest adding the words "or a committee of the board" in the first sentence after the words "disclose whether or not the board of directors" to recognize that compensation-related duties can be delegated. |
We have amended subsection 2.1(5) to include the words "or a committee of the board". |
||||
|
||||||
2.12 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (environmental, social and governance risks) |
|
|
|
||
|
||||||
|
Six commenters suggest that the CD&A should be expanded to require disclosure concerning a company's compensation policies and practices as they relate to environmental, social and governance (ESG) risks. If a company does not have an ESG policy with regard to compensation, it should be mandated to disclose this. Moreover, if a company has a policy relating to ESG metrics to executive compensation, it should be required to disclose this policy. |
We do not think that additional amendments to the commentary to section 2.1 of the Form are necessary to respond to these comments. The current commentary to section 2.1 of the Form includes the following example: |
||||
|
||||||
|
|
|
• |
compensation policies and practices that do not include effective risk management and regulatory compliance as part of the performance metrics used in determining compensation |
||
|
||||||
|
|
|
We believe that the example described above would include ESG risks that may have a material adverse effect on the company and ESG policies designed to mitigate risks with respect to the company's compensation policies and practices. We note that a company seeking additional guidance on disclosure of environmental matters, including risks, should refer to CSA Staff Notice 51-333 Environmental Reporting Guidance. |
|||
|
||||||
|
|
|
We also note that, if a company's executive compensation decisions are based on ESG metrics and/or risks, disclosure of NEO pay in relation to these ESG metrics and/or risks must be provided if necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. We also note that such disclosure may be required to be included in the CD&A under subsection 2.1(1) of the Form if necessary to describe or explain the objectives of any compensation program or strategy, or how each element of compensation and the company's decisions about that element fit into the company's overall compensation objectives and affect decisions about other elements. |
|||
|
||||||
2.13 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (additional issues that a company may consider to discuss and analyze) |
|
|
|
||
|
||||||
|
Two commenters suggest adding language to the commentary to include examples and clarify that the list of situations, provided as commentary, that a company may consider to discuss and analyze in determining whether executive officers could be encouraged to take inappropriate or excessive risks is not exhaustive. |
We have amended the commentary to section 2.1 to clarify that examples of situations that could potentially encourage an executive officer to expose the company to inappropriate or excessive risks provided in the commentary are not exhaustive. |
||||
|
||||||
|
While most commenters agreed that the examples provided in the supporting commentary were useful, the commenters suggested that we expand the commentary to include additional examples of excessive risk taking through pay practices such as: |
We think that many of the examples suggested by the commenters are already included in the commentary to section 2.1. We have, however, amended the commentary to section 2.1 of the Form to include some of the suggested examples that were not included in the proposed amendments for comment, including: |
||||
|
||||||
|
• |
Incentive plans based on financial results that do not have a maximum benefit or "cap". |
• |
incentive plan awards that do not provide a maximum benefit or payout limit to executive officers. |
||
|
||||||
|
• |
The use of discretion to adjust NEO compensation after it is determined under previously approved criteria. |
|
|
|
|
|
||||||
|
• |
Decision-making structures in which executive officers are determining their own compensation or conflicts of interest on the compensation involving directors who are also NEOs of other companies. |
|
|
|
|
|
||||||
|
• |
Large retention bonuses or guaranteed compensation set out in multi-year employment contracts without a performance linkage. |
|
|
|
|
|
||||||
|
• |
Excessive single trigger change in control and severance agreements that can result in excessive payouts to executive officers and directors for supporting a change in control. |
|
|
|
|
|
||||||
|
• |
Interest-free or low interest loans extended by a company to executive officers for the purpose of exercising options or acquiring equity awards. |
|
|
|
|
|
||||||
|
• |
The ability of executive officers to hedge downside risks related to variable compensation. |
|
|
|
|
|
||||||
|
• |
General omission of timely information necessary to understand the company's compensation policies and practices, including the omission of material contracts, agreements or other shareholder disclosure documents. |
|
|
|
|
|
||||||
|
The commenters also suggest that we include commentary which includes examples of compensation policies and practices that the company has adopted to mitigate risks such as: |
We have not amended the commentary to section 2.1 of the Form to include the suggested examples. We note that paragraph 2.1(5)(b) requires the company to disclose any practices the company uses to identify and mitigate compensation policies and practices that could encourage an NEO or individual at a principal business unit or division to take inappropriate or excessive risks. |
||||
|
||||||
|
• |
Undertaking scenario analysis to stress test the company's compensation policies and practices. |
|
|
|
|
|
||||||
|
• |
Compensation policies and practices (such as clawback or "malus" polices) that require repayment or forfeiture of compensation earned by taking excessive risks. |
|
|
|
|
|
||||||
|
• |
Share ownership guidelines. |
|
|
|
|
|
||||||
2.14 |
Paragraph 2.1(5)(c) - Disclosure of risks associated with compensation policies and practices (identified risks) |
|
|
|
||
|
||||||
|
One commenter suggests that we amend paragraph 2.1(5)(c) to clarify that a discussion of risks that are reasonably likely to have a material adverse effect on the company should be included even if the board has not identified any compensation policies and practices that are reasonably likely to have a material adverse effect on the company. |
We have not made the suggested change. By focusing the requirement to risks that are reasonably likely to have a material adverse effect on the company, we think that investors will have sufficient information to make more informed voting and investment decisions. |
||||
|
||||||
2.15 |
Subsection 2.1(5) - Disclosure of risks associated with compensation policies and practices (continuous disclosure review) |
|
|
|
||
|
||||||
|
Two commenters suggest that the CSA commit to conduct a review of the risk disclosures within two years and then refine these requirements to encourage more uniform and complete disclosure. |
We note that we closely monitor new rules in the first year of implementation to ensure that they are working as intended. We also note that we have an ongoing commitment to conduct normal course continuous disclosure reviews. These reviews typically include consideration of a company's executive compensation disclosure. Though we do not generally disclose the result of individual reviews, we may publish additional guidance in the form of a staff notice if we find recurring deficiencies or themes in the disclosure that we believe will be of interest to other companies. If warranted, such a staff notice may provide additional guidance on the disclosure of risks associated with compensation policies and practices. |
||||
|
||||||
2.16 |
Subsection 2.1(6) - Disclosure regarding NEO or director hedging (general) |
|
|
|
||
|
||||||
|
Nine commenters support the proposed amendment to require companies to disclose whether the NEOs or directors are permitted to purchase financial instruments that are designed to hedge or offset a decrease in the market value of equity securities granted as compensation or held by the NEO or director. Two commenters also expect that this proposed requirement will cause companies to introduce explicit policies prohibiting hedging of equity-based compensation awards and securities held under share-ownership requirements. |
We thank the commenters for their support. |
||||
|
||||||
|
One commenter believes that any hedging transactions from NEOs or directors should be strictly prohibited. |
We have not made the suggested change. The objective of executive compensation disclosure is to communicate the compensation policies and practices of the company as opposed to endorsing or prohibiting particular compensation practices or policies. |
||||
|
||||||
|
Four commenters did not think the proposed amendment would provide useful information to investors and were of the view that the insider reporting requirements on SEDI already require companies to disclose whether NEOs or directors engage in any hedging transactions. If the CSA decides to include this requirement in the CD&A, the commenters suggest that the proposed requirement should not focus on whether any NEO or director is permitted to engage in any hedging activities but whether or not any NEO or director has in fact done so during the previously completed financial year. |
We acknowledge these comments. However, we think that the ability of a director or an NEO to engage in any hedging transactions is a potential risk that could have a material adverse effect on the company. We think that companies will have enough flexibility to provide the disclosure they deem necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
2.17 |
Subsection 2.1(6) - Disclosure regarding NEO or director hedging (additional disclosure) |
|
|
|
||
|
||||||
|
Two commenters suggest that, in addition to the proposed disclosure requirement, companies should also be required to disclose in plain language whether any NEOs and directors, during the most recently completed financial year, engaged in any hedging activities, including a description of the actual hedging instruments. These commenters also argue that providing the names of NEOs or directors who have engaged in hedging activities will not impose additional costs to companies and will allow investors to perform a more targeted and efficient search in SEDI to determine whether a significant misalignment of interests has occurred. |
We acknowledge these comments but do not propose to amend the Form to include this suggested change at this time. We note, however, companies may choose to disclose, whether any NEOs and directors, during the most recently completed financial year, engaged in any hedging activities, including a description of the actual hedging instruments, if necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
2.18 |
Section 2.2 - Performance graph |
|
|
|
||
|
||||||
|
One commenter recommends that, in addition to the present requirement, companies should be required to compare the cumulative total shareholder return against a sector performance metric specific to the company and industry. |
We have not made the suggested change. Section 2.2 does not require companies to use a single performance metric. Companies may use any performance metric they see fit to describe and justify their compensation policies and practices, provided that these performance metrics do not detract from the provision of meaningful and accessible disclosure of compensation information. We note that companies must disclose other pertinent performance metrics, if necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
2.19 |
Paragraph 2.4(2)(a) - Compensation committee (names of committee members) |
|
|
|
||
|
||||||
|
One commenter suggests that paragraph 2.4(2)(a) be amended to provide the names of each compensation committee member and, in respect of each member, whether or not the member is independent or is not independent. The current provision only requires the company to disclose whether "the committee is composed entirely of independent directors", and does not require disclosure concerning the independence of each member of the compensation committee. |
We have amended paragraph 2.4(2)(a) to read: |
||||
|
||||||
|
The same commenter further suggests that subsection 2.4(2) of the proposed amendments be amended to provide the following disclosures in respect of the members of the compensation committee, in addition to stating whether each member is independent or not independent: |
"disclose the name of each committee member and, in respect of each member, state whether or not the member is independent or not independent." |
||||
|
||||||
|
|
|
We have not amended the Form to include this suggested change. The definition of director independence for audit committee composition and corporate governance purposes is found in National Instrument 52-110 Audit Committees (NI 52-110). Subject to the "bright-line" tests in subsection 1.4(3) of NI 52-110, a director is independent if he or she has no direct or indirect material relationship with the company. As noted in CSA Staff Notice 58-305 Status Report on the Proposed Changes to the Corporate Governance Regime, the CSA decided, based on the comments received, to not implement proposed changes to the corporate governance regime originally published on December 19, 2008. |
|||
|
||||||
|
(i) |
A description of any relationship with the company or its affiliated or subsidiary entities, with a significant shareholder of the issuer or with any of the executive officers of the issuer that the board of directors considered in determining the director's independence; and |
|
|
|
|
|
||||||
|
(ii) |
If the director has a relationship referred to in paragraph (i), a discussion of why the board of directors considers the director to be independent. |
|
|
|
|
|
||||||
2.20 |
Paragraph 2.4(2)(c) - Compensation committee (skills and experience of committee members) |
|
|
|
||
|
||||||
|
One commenter noted that the proposed paragraph (c) about compensation committee's skills and experience reflects the increasing importance shareholders are attaching to compensation matters, as well as an acknowledgement of the complexity of the issues considered by the compensation committee. |
We thank the commenter for its support. |
||||
|
||||||
|
One commenter is concerned that the disclosure required under paragraph (c) could increase the chances that a director will be singled out in civil litigation by virtue of having certain "skills" or qualifications. |
We disagree. We note that the disclosure required under paragraph (c) does not impose any additional legal obligations or increase a director's fiduciary obligations and their responsibility to manage or supervise the management of the business and affairs of the company. We think this additional disclosure improves the quality of disclosure provided to investors and will satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form to provide insight into executive compensation as a key aspect of the overall stewardship and governance of the company. |
||||
|
||||||
|
One commenter believes that the proposed paragraph (c) appears to be an unduly narrow focus on the skills and experience that are relevant to a compensation committee member's duties and responsibilities. If such disclosure is required, the commenter questions whether all experience and expertise relevant to making decisions as to compensation policies and practices be appropriately disclosed. |
We disagree. Please see our response immediately below. |
||||
|
||||||
|
Five commenters believe that the appropriate requirement regarding skills and experience should focus on the composition of the board as a whole in order to ensure that the board has the right mix of skills and competencies. Four commenters suggest that we amend paragraph 2.4(2)(c) to read: |
We have amended paragraph 2.4(2)(c) the Form by removing the words "that are consistent with a reasonable assessment of the company's risk profile" because we think that these words are unnecessary and confusing. We also think that these words detracted from the intent of paragraph 2.4(2)(c) to disclose the skills and experience relevant to making decisions about the company's compensation policies and practices. |
||||
|
||||||
|
"describe the skills and experience that enable the board of directors or a committee of the board to make decisions on the suitability of the company's compensation policies and practices;". |
However, we have not amended the Form to extend the disclosure requirement to the board of directors. The requirements in subsection 2.4(2) of the Form apply to companies who have established a compensation committee. If the company has not established a compensation committee, we think that the company may describe the skills and experience that enable the board of directors to make decisions on the suitability of the company's compensation policies and practices as part of the requirements in subsection 2.4(1) of the Form. |
||||
|
||||||
|
The commenters also suggest that we provide guidance on the expected disclosure similar to the guidance under Part 4 of the Companion Policy to NI 52-110 Audit Committees with respect to financial literacy, financial education and experience. The commenters view that the proposed requirement seems to be more difficult to meet and less clear than what is required in NI 52-110. |
We do not propose to include additional commentary to the Form in response to these comments. We think that it is more appropriate for the board of directors to determine the skills and experience that its directors have with respect to determining the suitability of the company's compensation policies and practices. We note, however, that though we have not provided additional commentary at this time, we closely monitor new requirements in the first year after implementation. |
||||
|
||||||
|
One commenter suggests that we amend the proposed requirement to encourage the disclosure of committee members' education and training in compensation matters. |
We acknowledge these comments but do not propose to amend the Form to include this suggested change at this time. |
||||
|
||||||
2.21 |
Paragraph 2.4(3)(c) - Compensation consultants or advisors |
|
|
|
||
|
||||||
|
Two commenters suggest that paragraph 2.4(3)(c) be amended to clarify that disclosure is required if the consultant or advisor or any of its affiliates has provided any services for the company, any of its affiliated or subsidiary entities, or any of its directors or members of management other than or in addition to compensation services for any of the company's directors or executive officers. |
We have amended paragraph 2.4(3)(c) of the Form to read: |
||||
|
||||||
|
|
|
"If the consultant or advisor has provided any services to the company, or to its affiliated or subsidiary entities, or to any of its directors or members of management, other than or in addition to compensation services provided for any of the company's directors or executive officers, |
|||
|
||||||
|
|
|
|
(i) |
state this fact and briefly describe the nature of the work, |
|
|
||||||
|
|
|
|
(ii) |
disclose whether the board of directors must pre-approve other services the consultant or advisor, or any of its affiliates, provides to the company at the request of management." |
|
|
||||||
|
One commenter suggests that, whether disclosing the fees paid by the company to the consultant for other services to the company will assist investors in assessing potential conflicts of interest, the proposed amendments should be revised to provide that companies are required to disclose all potential conflicts of interest relating to their compensation consultants. For example, if a compensation consultant is involved in determining the compensation for a member of the compensation committee of a company who is also an executive at another company, the commenter states that this would be a potential conflict of interest that should be disclosed, but would not be captured by the proposed amendment. |
We have not amended the Form to include this suggested change. By focusing the requirement on other services performed to the company and a breakdown of all fees provided, we think that investors will have sufficient information to make more informed voting and investment decisions. |
||||
|
||||||
2.22 |
Paragraph 2.4(3)(d) - Disclosure of fees paid to compensation consultants and advisors (generally) |
|
|
|
||
|
||||||
|
Generally, eight commenters support the proposed requirement to disclose fees paid to compensation consultants and advisors for each service provided in all circumstances and think that the disclosure of the fees paid to compensation consultants or advisors is useful to assess the company's compensation policies and practices. |
We thank the commenters for their support. |
||||
|
||||||
|
Two commenters do not support the proposed requirement and are concerned that such disclosure will merely further drive upward the costs of compensation determination. |
We disagree. We think the requirement to provide a breakdown of all fees paid to compensation consultants or advisors for each service provided will enhance the transparency of the company's compensation policies and practices and will provide investors with clearer and more meaningful executive compensation disclosure. |
||||
|
||||||
|
Six commenters think that there should be no disclosure obligation to disclose the fees of compensation consultants and advisors who did not provide additional services to the company. |
We have not amended the Form to include this suggested change. We believe that the disclosure of fees paid to compensation consultants provides meaningful information about the company's compensation policies and practices in all situations, regardless of whether the compensation consultant or advisor provided other services to the company. |
||||
|
||||||
2.23 |
Paragraph 2.4(3)(d) - Disclosure of fees paid to compensation consultants and advisors (definition) |
|
|
|
||
|
||||||
|
Two commenters request that we clarify whether "compensation consultant or advisor" would include legal, accounting, tax and other advisors. |
We confirm that compensation consultant or advisor does not include legal, accounting and tax. We note that the previous requirement in Item 7(d) of Form 58-101F1 Corporate Governance Disclosure also included the words "compensation consultant or advisor". We do not think that an amendment to paragraph 2.4(3)(d) of the Form is necessary in response to these comments. |
||||
|
||||||
2.24 |
Paragraph 2.4(3)(d) - Disclosure of fees paid to compensation consultants and advisors (materiality threshold) |
|||||
|
||||||
|
Eight commenters agree that we should not impose a materiality threshold in disclosing the fees paid to compensation consultants or advisors. |
We thank the commenters for their support. Consistent with the proposed amendment published for comment, paragraph 2.4(3)(d) of the Form does not include a materiality threshold. |
||||
|
||||||
|
Five commenters believe that there should be a fee materiality threshold consistent with the approach adopted by the SEC (e.g. US$120,000). |
We thank the commenters for their comments. However, we do not propose to amend the Form to include the suggested changes at this time. |
||||
|
||||||
|
In addition, where fee disclosure is required because it exceeds the threshold, two commenters suggest that the total fees charged by the consultant for all services rendered should also be expressed in relation to the total revenues of the consulting firm so that the reader can have a sense of the materiality of fees. One commenter suggests that the following information should also be disclosed: |
|
|
|
||
|
||||||
|
• |
The number of company shares held by the compensation expert or his firm, and |
|
|
|
|
|
||||||
|
• |
Any business relationship between the compensation expert and a member of the board directors, a member of the compensation committee, or with companies with which board members have professional relationships. |
|
|
|
|
|
||||||
2.25 |
Paragraph 2.4(3)(d) - Disclosure of fees paid to compensation consultants and advisors (materiality threshold) |
|
|
|
||
|
||||||
|
One commenter requests that we clarify that companies must disclose the aggregate fees paid to each compensation consultant or advisor retained on a "per consultant basis" and may not aggregate the amounts paid to all consultants. |
We confirm that companies must disclose aggregate fees paid on a "per consultant" basis. We have amended subparagraphs 2.4(3)(d)(i) and (ii) in response to this comment. |
||||
|
||||||
ITEM 3 SUMMARY COMPENSATION TABLE (SCT) |
||||||
|
||||||
3.1 |
Subsection 3.1(4) - Fair value of option-based awards |
|
|
|
||
|
||||||
|
One commenter suggests that we amend the requirement for disclosure of the fair value of option-based awards granted to provide that, where option-based awards are performance-based, and the results of the formula are known when the disclosure is prepared, the amount to be included in the SCT should be the net value of the option-based awards that the NEO actually received on the achievement of the performance measures. The commenter also states that the current requirement permits companies to alter the layout of the SEC in order to disclose its total compensation more fully and accurately. |
Please see our response to comment 1.3. Under subsection 1.3(2) of the Form, a company may not alter the presentation of the SCT by adding columns or other information. Subparagraph 1.3(2)(a)(ii) also clarifies that companies may choose to add another table, column or other information, so long as the additional information does not detract from the SCT prescribed in section 3.1 of the Form. |
||||
|
||||||
3.2 |
Subsection 3.1(5) - Reconciliation to "accounting fair value" |
|
|
|
||
|
||||||
|
Five commenters support the proposed amendment to require, in all circumstances, companies to disclose the methodology used to calculate grant date fair value of all equity-based awards, including key assumptions and estimates used for each calculation and why the company chose that methodology. |
We thank the commenters for their support. |
||||
|
||||||
|
Conversely, four commenters believe that companies should be allowed to cross-reference to their financial statements with respect to the methodology used to calculate grant date fair value of equity-based awards. |
We disagree. We have not amended the Form to make the suggested change. We think that disclosing the methodology, including the key assumptions and estimates, used to calculate the accounting fair value reported in the company's SCT provides useful information to investors in all circumstances |
||||
|
||||||
|
One commenter believes that the requirement to describe the methodology and disclose the key assumptions used in calculating grant date fair value would not provide useful information to investors and would require significant time commitments for companies to prepare and for investors to interpret. The commenter said that companies often use different sets of assumptions to value grants made to different groups of employees and also note that when grants are made at various dates during the year, the assumptions will vary from one grant to another and disclosure of each would potentially result in an excessive amount of information. |
|
|
|
||
|
||||||
3.3 |
Subsection 3.1(10) - All other compensation |
|
|
|
||
|
||||||
|
One commenter suggests that we clarify that column (h) "all other compensation" should only be confined to perquisites that are not properly characterized as salary or bonus payments and that cash payments made in lieu of pension benefits that are essentially characterized as part of a salary or bonus should not be disclosed in column "h". |
We do not think that any further amendment to the Form is necessary. Subsection 3.1(13) of the Form provides that any compensation an NEO elects to exchange must be reported as compensation in the column appropriate for the form of compensation exchanged. |
||||
|
||||||
3.4 |
Paragraph 3.1(10)(i) - Personal registered retirement savings plan |
|
|
|
||
|
||||||
|
One commenter suggests that we replace the words "to a personal registered retirement savings plan" with "to a personal savings plan like a registered retirement savings plan". |
We have amended paragraph 3.1(10)(i) of the Form to read: "any company contribution to a personal savings plan like a registered retirement savings plan made on behalf of the NEO". This would include any registered retirement savings plan sponsored by the company. |
||||
|
||||||
|
Two commenters ask whether this change applies equally to "Group" RRSPs sponsored by the company as well as to individual RRSPs and ask that the word "personal" be deleted from the proposed wording. |
|
|
|
||
|
||||||
ITEM 4 - INCENTIVE PLAN AWARDS |
||||||
|
||||||
4.1 |
Subsection 4.1(7) - Market or payout value of share-based awards that have not vested |
|
|
|
||
|
||||||
|
One commenter explains that many companies prefer to report their unvested share-based awards in the table at target, rather than at threshold or on some other basis, as they believe that this disclosure is more useful information to provide to investors. The commenter also explains that, in many share-based award plans with performance vesting requirements, the minimum payout is nil if the threshold performance requirements are not met. |
We acknowledge the comment but have not amended the Form to make the suggested change. Companies should present this information in the clearest manner possible. Companies may report the market or payout value of unvested share-based awards at target if they believe the disclosure is necessary in order to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. |
||||
|
||||||
4.2 |
Subsection 4.1(8) - Disclosure of market value of vested share-based awards |
|
|
|
||
|
||||||
|
Two commenters recommend that we remove the requirement to disclose the aggregate market value or payout value of vested share-based awards that have not been paid or distributed. The commenters felt that the proposed requirement may generate double-counting of the same compensation. |
We have not amended the Form in response to these comments. The requirement to disclose the aggregate market value or payout value of vested share-based awards that have not paid out or distributed is different and serves a different purpose than the requirement in subsection 4.2(3) of the Form, since the table required by subsection 4.2(1) of the Form is intended to capture the value of all awards that were vested or earned during the most recently completed financial year. |
||||
|
||||||
|
To address these concerns, one commenter suggests that we add an additional column entitled "Number of shares or units of shares that have vested and have not been paid out or distributed". |
We have not made the suggested change. Please see our response above. |
||||
|
||||||
4.3 |
Section 4.2 - Value vested or earned during the year |
|
|
|
||
|
||||||
|
One commenter recommends that we delete column (d) of this table for non-equity incentive plan compensation because the column merely reiterates the same amounts described in the SCT for the current year. |
We have not made the suggested change. While we acknowledge that the value reported in column (d) of the "Value vested or earned during the year" table will be the same value, or the sum of the value reported for annual incentive plans and long-term incentive plans, that is disclosed in the SCT under subsection 3.1(8), we think that the table required by subsection 4.2(1) of the Form serves a different purpose than the SCT and is intended to capture the value of all awards that were vested or earned during the most recently completed financial year. |
||||
|
||||||
ITEM 5 - PENSION PLAN BENEFITS |
||||||
|
||||||
5.1 |
Subsection 5.1(4) - Commentary (calculation of annual benefits payable at year-end) |
|
|
|
||
|
||||||
|
Two commenters disagree with the proposed formula for calculating the annual benefit payable at year end for the following reasons: |
We have amended subsection 5.1(4) of the Form in response to these comments. Paragraph 5.1(4)(a) reads as follows: |
||||
|
||||||
|
|
|
"In column (c), disclose |
|||
|
||||||
|
• |
There is not necessarily one single "presumed retirement age" used to calculate the present value of the obligation. Rather, a company may be assuming probabilities of retirement at various ages. |
|
(a) |
the annual lifetime benefit payable at the end of the most recently completed financial year in column (c1) based on years of credited service reported in column (b) and actual pensionable earnings as at the end of the most recently completed financial year. For purposes of this calculation, the company must assume that the NEO is eligible to receive payments or benefits at year end" |
|
|
||||||
|
• |
Using the benefit payable at the presumed retirement age and multiplying it by the ratio of years of credited service at year end to years of credited service at presumed retirement age is different than current practice. |
|
|
|
|
|
||||||
|
• |
It is not appropriate to prorate over credited service at year end in all pension designs. |
|
|
|
|
|
||||||
|
Both commenters suggest that paragraph 5.1(4)(a) should prescribe a specific age, such as age 65, which will enable comparison of information from one reporting period to the next. In the alternative, one of the commenters suggests we should remove the proposed formula. |
We have also amended the commentary to subsection 5.1(4) to clarify that a company may calculate the annual lifetime benefit payable in accordance with the methodology included in the commentary or in accordance with another formula if the company reasonably believes that it produces a more meaningful calculation of the annual lifetime benefit payable at year end. |
||||
|
||||||
5.2 |
Subsection 5.2(3) Non-compensatory amounts |
|
|
|
||
|
||||||
|
Thirteen commenters do not object to the elimination of the requirement to disclose employee contributions and regular investment earnings on employer and employee contributions. |
We thank the commenters for their comments. In response to the comments, we have deleted subsection 5.2(3) of the Form. We note, however, that the other requirements in section 5.2 of the Form remain the same. |
||||
|
||||||
|
Four commenters believe that column (d) of the defined contribution plans table should be maintained since the non-compensatory amount would also include deemed investment earnings on the defined contribution accumulations to the extent they are not considered above-market or preferential earnings and would create a liability to the company. |
|
|
|
||
|
||||||
5.3 |
Section 5.2 - Defined contribution plans table (accumulated value at start of year) |
|
|
|
||
|
||||||
|
One commenter suggests deleting column (b) "accumulated value at start of year", if column (d) "non-compensatory amount" is deleted, leaving the defined contribution plan table to simply show the compensatory amount (currently column (c)) and the accumulated value at year end (currently column (e)). |
We have not amended the Form in response to this comment. We think that including the "accumulated value at start of year" column provides meaningful information to investors and will facilitate year-to-year comparisons of the accumulated value of defined contribution plans. |
||||
|
||||||
5.4 |
Section 5.2 (Commentary) |
|
|
|
||
|
||||||
|
||||||
|
One commenter suggests that the proposed wording to commentary number 2 should be revised to the following: |
We have amended the commentary to section 5.2 of the Form to read: |
||||
|
||||||
|
"Registered retirement savings plans can be excluded from the defined contribution plans tables, however, any contributions made by the company or a subsidiary of the company to a registered retirement savings plan on behalf of the NEO must still be disclosed in column (h) of the Summary Compensation Table, as required by paragraph 3.1(10)(i)." |
"Any contributions made by the company or a subsidiary of the company to a personal savings plan like a registered retirement savings plan made on behalf of the NEO must still be disclosed in column (h) of the Summary Compensation Table, as required by paragraph 3.1(10)(i)." |
||||
|
||||||
AMOUNT REALIZED UPON EXERCISE OF EQUITY AWARDS |
||||||
|
||||||
6.1 |
Six commenters do not support the CSA's intention of not reintroducing the requirement to disclose the amount realized from the exercise of stock options. |
We thank the commenters for their comments. We continue to think that the executive compensation disclosure rules should be focused on the board's compensation-based decisions, rather than the executive officer's investment decisions. |
||||
|
||||||
|
The commenters made the following additional comments in support of reintroducing the requirement: |
While we not intend to reintroduce this requirement at this time, we note however that, as part of the rulemaking process, we intend to monitor these developments and may consider additional communication with stakeholders to address any issues that arise as a result of this monitoring process. |
||||
|
||||||
|
• |
The disclosure provided at the time of grant is an estimate of what the Board believes it was paying the NEO and does not provide information on what the NEO actually received. |
|
|
|
|
|
||||||
|
Six commenters support the CSA's intention not to reintroduce this requirement and made the following additional comments against reintroducing the requirement. |
|
|
|
||
|
||||||
|
• |
The current disclosure requirements with respect to grant date fair value already assume that the issuer takes into account the fair market value of equity grants. A requirement to disclose the amount realized upon exercise of equity awards is duplicative and misleads the reader to think that the executive has obtained a new benefit from the issuer, where the expected benefits were already disclosed at the time of grant. |
|
|
|
|
|
||||||
|
• |
Disclosing the amount realized from previous grants shifts the focus away from the compensation decisions made during the given year. |
|
|
|
|
|
||||||
CONSEQUENTIAL AMENDMENTS |
||||||
|
||||||
7.1 |
Amendment instruments for Form 58-101F1 and Form 58-101F1 |
|
|
|
||
|
||||||
|
One commenter suggests that we substitute the word "may" with the word "must" in the instruction to Form 58-101F1 and Form 58-101F2. |
We have not made the suggested drafting change. |
||||
|
||||||
OTHER ISSUES |
||||||
|
||||||
8.1 |
Clawbacks |
|
|
|
||
|
||||||
|
One commenter recommends that the commentary regarding executive clawback provisions be elevated into a disclosure requirement to advise investors whether the company has adopted executive clawback provisions, the material terms of any such policy and any proceedings initiated under the policy. |
We have not amended the Form in response to this comment. Companies must determine whether disclosure of a policy or of the absence of a policy on clawbacks is necessary to satisfy the requirements in subsection 2.1(1) of the Form that the CD&A discusses all significant principles underlying the policies in place and decisions made in respect to compensation provided to NEOs for the most recently completed financial year. We also note that the adoption of a policy or the absence of a policy on clawbacks may be included in the consideration of risks associated with the company's compensation policies and practices. |
||||
|
||||||
8.2 |
Certification of Compensation Discussion & Analysis (CD&A) |
|
|
|
||
|
||||||
|
One commenter suggests that we require the members of the compensation committee to review and approve the CD&A in order to make it clear that the compensation committee is responsible for the preparation of the CD&A. |
We have not made the suggested change. Form 52-109F1 Certification of Annual Filings of National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings requires that a non-venture issuer attest that it has designed disclosure controls and procedures over financial reporting and evaluated the effectiveness of controls procedures. These controls and procedures should cover the executive compensation disclosure. |
||||
|
||||||
8.3 |
Form 51-102F5 - Information Circular (Indebteness of Directors and Executive Officers) |
|
|
|
||
|
||||||
|
One commenter suggests that we consider making consequential amendments to item 10 of Form 51-102F5, in particular: |
We have not made the suggested change. Revisiting the indebtedness requirements for directors and executive officers is beyond the scope of this initiative. We have forwarded this comment to the CSA committee responsible for NI 51-102. |
||||
|
||||||
|
• |
restricting the disclosure to NEO's and directors, |
|
|
|
|
|
||||||
|
• |
in paragraph 10.3(c)(i), increasing the threshold from $50,000 to $250,000, to reflect a more relevant current threshold of materiality, |
|
|
|
|
|
||||||
|
• |
in paragraph 10.3(c)(ii), substituting "annual cash compensation" for salary, and |
|
|
|
|
|
||||||
|
• |
in paragraph 10.3(c)(iii), extending the exemption to employees and for loans under a specified amount (e.g. $250,000). |
|
|
|
|
|
||||||
8.4 |
Minimum shareholding requirements |
|
|
|
||
|
||||||
|
One commenter suggests that we adopt a requirement to disclose the company's minimum shareholding requirements and the attainment of shares against these levels by each NEO or at least specifically include a reference to it in commentary under subsection 2.1(1) of the Form. |
We have not amended the Form in response to this comment. We note, however, that when a company's executive compensation decisions are based on aligning these interests, disclosure of equity ownership guidelines and levels must be provided if necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. We also note that such disclosure may be required to be included in the CD&A under subsection 2.1(1) of the Form if necessary to describe or explain the objectives of any compensation program or strategy, or how each element of compensation and the company's decisions about that element fit into the company's overall compensation objectives. |
||||
|
||||||
8.5 |
Proposed rules regarding CEO-employee pay ratios |
|
|
|
||
|
||||||
|
Two commenters recommend that companies should be required to produce "pay ratio" disclosure, which would set out the relative pay of three categories of company personnel: (i) the CEO; (ii) the NEOs; and (iii) the average pay of non-executive employees of the company and its subsidiaries. |
We have not amended the Form in response to these comments. We do not think that the benefits of disclosing a pay ratio between the CEO and the average pay of non-executive employees of the company would outweigh the additional costs imposed to companies in preparing this disclosure. |
||||
|
||||||
|
In addition, two commenters recommend that we propose an amendment requesting disclosure comparing the ratio of total compensation for a company's executive officers (including those below the NEO level) to the company's total earnings. |
|
|
|
||
|
||||||
8.6 |
Cost of management ratio (COMR) disclosure |
|
|
|
||
|
||||||
|
In situations where compensation policies and practices where the compensation expense to executive officers is a significant percentage of the company's revenue, one commenter recommends that the Form be amended to include a requirement for companies to provide COMR disclosure which is the ratio of total NEO pay to net income after tax. The commenter notes that COMR is a measure already used by some Canadian companies. |
We have not amended the Form in response to this comment. We note, however, that when a company's executive compensation decisions are based on COMR, disclosure of NEO pay to net income after tax must be provided if necessary to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form. We also note that such disclosure may be required to be included in the CD&A under subsection 2.1(1) of the Form if necessary to describe or explain the objectives of any compensation program or strategy, or how each element of compensation and the company's decisions about that element fit into the company's overall compensation objectives and affect decisions about other elements. |
||||
|
||||||
8.7 |
Additional "pay for performance" tables and CD&A disclosure |
|
|
|
||
|
||||||
|
One commenter suggests that the CD&A requirements should be expanded to provide two prescribed tables along with narrative disclosure. The first table would disclose actual pay earned in the reporting year and the corresponding performance achieved, and the second table would disclose the estimated potential future pay from long-term incentives, compared with the performance required to earn the estimated amounts. |
We have not amended the Form in response to these comments. In order to satisfy the objective of executive compensation disclosure set out in section 1.1 of the Form, we encourage methods of presentation that are tailored to a particular company's circumstances if the additional disclosure will help investors understand how decisions about executive compensation are made. |
||||
|
||||||
|
In the absence of these two additional tables, companies should be encouraged to disclose in the CD&A how the size and terms of equity-based awards are determined with respect to performance and other factors, and whether grants reported in the SCT are relevant to a previous year's performance. If that is the case, the company should separately disclose the number and value of the stock and option awards made in the current year that are related to the service in the most recently completed financial year, for shareholders to consider when evaluating the pay for performance link. |
|
|
|
||
|
||||||
|
In addition, one commenter encourages the CSA to clarify that companies can provide additional narrative disclosure in the CD&A if it will assist investors in understanding the board's approach to compensation. |
|
|
|
||
|
||||||
8.8 |
Executive compensation disclosure for special meetings |
|
|
|
||
|
||||||
|
One commenter recommends that we amend NI 51-102 to provide that executive compensation disclosure in an information circular for a special meeting should be mandatory when shareholders are asked to approve a compensation plan. The commenter thinks that a reporting issuer should not have the ability to use a special meeting to sidestep disclosing information necessary for shareholders to assess the compensation plans they are being asked to approve. |
We have not made the suggested change. Revisiting the disclosure requirements in respect of special meetings is beyond the scope of this initiative. We have forwarded this comment to the CSA committee responsible for NI 51-102. |
APPENDIX D
Amendments to National Instrument 51-102 Continuous Disclosure Obligations
Although this amendment instrument amends section headers in Form 51-102F6, section headers do not form part of the instrument and are inserted for ease of reference only.
1. National Instrument 51-102 Continuous Disclosure Obligations is amended by this Instrument.
2. Section 1.1 of Form 51-102F6 Statement of Executive Compensation (in respect of financial years ending on or after December 31, 2008) is amended by
(a) deleting "the board of directors intended",
(b) replacing "to pay, make payable, award, grant, give or otherwise provide"with "paid, made payable, awarded, granted, gave or otherwise provided",
(c) adding ", and the decision-making process relating to compensation" after "financial year", and
(d) adding "and subsections 9.3.1(1) or 11.6(1) of the Instrument"after "objective.".
3. Section 1.2 of Form 51-102F6 is amended by
(a) in the definition of "NEO or named executive officer",
(i) adding "of the company, including any of its subsidiaries"after "executive officers", and
(ii) adding "or its subsidiaries" after "company".
4. Section 1.3 of Form 51-102F6 is amended by
(a) in subsection (1), adding "and for services to be provided"after "services provided",
(b) in subsection (2),
(i) replacing paragraphs (a) and (b) with the following:
(a) Although the required disclosure must be made in accordance with this form, the disclosure may
(i) omit a table, column of a table, or other prescribed information, if it does not apply, and
(ii) add a table, column, or other information if
(A) necessary to satisfy the objective in section 1.1, and
(B) to a reasonable person, the table, column, or other information does not detract from the prescribed information in the summary compensation table in section 3.1.
(b) Despite paragraph (a), a company must not add a column in the summary compensation table in section 3.1.
(c) in subsection (4),
(i) in paragraph (c), repealing clause (c)(i), and
(ii) in paragraph (c), replacing paragraph (c) with the following:
(c) If an external management company provides the company's executive management services and also provides executive management services to another company, disclose the entire compensation the external management company paid to the individual acting as an NEO or director, or acting in a similar capacity, in connection with services the external management company provided to the company, or the parent or a subsidiary of the company. If the management company allocates the compensation paid to an NEO or director, disclose the basis or methodology used to allocate this compensation.
(d) in subsection (8), replacing "for any part of that"with "at any time during the most recently completed", and
(e) adding the following subsections:
(9) Currencies
Companies must report amounts required by this form in Canadian dollars or in the same currency that the company uses for its financial statements. A company must use the same currency in the tables in sections 3.1, 4.1, 4.2, 5.1, 5.2 and 7.1 of this form.
If compensation awarded to, earned by, paid to, or payable to an NEO was in a currency other than the currency reported in the prescribed tables of this form, state the currency in which compensation was awarded, earned, paid, or payable, disclose the currency exchange rate and describe the methodology used to translate the compensation into Canadian dollars or the currency that the company uses in its financial statements.
(10) Plain language
Information required to be disclosed under this form must be clear, concise, and presented in such a way that it provides a reasonable person, applying reasonable effort, an understanding of,
(a) how decisions about NEO and director compensation are made; and
(b) how specific NEO and director compensation relates to the overall stewardship and governance of the company.
Commentary
Refer to the plain language principles listed in section 1.5 of Companion Policy 51-102CP Continuous Disclosure Obligations for further guidance.
5. Section 2.1 of Form 51-102F6 is amended by
(a) replacing subsection (4) with the following:
If applicable, disclose performance goals or similar conditions that are based on objective, identifiable measures, such as the company's share price or earnings per share. If performance goals or similar conditions are subjective, the company may describe the performance goal or similar condition without providing specific measures.
If the company discloses performance goals or similar conditions that are non-GAAP financial measures, explain how the company calculates these performance goals or similar conditions from its financial statements.
Exemption
The company is not required to disclose performance goals or similar conditions in respect of specific quantitative or qualitative performance-related factors if a reasonable person would consider that disclosing them would seriously prejudice the company's interests.
For the purposes of this exemption, a company's interest's are not considered to be seriously prejudiced solely by disclosing performance goals or similar conditions if those goals or conditions are based on broad corporate-level financial performance metrics which include earnings per share, revenue growth, and earnings before interest, taxes, depreciation and amortization.
This exemption does not apply if it has publicly disclosed the performance goals or similar conditions.
If the company is relying on this exemption, state this fact and explain why disclosing the performance goals or similar conditions would seriously prejudice the company's interests.
If the company does not disclose specific performance goals or similar conditions, state what percentage of the NEO's total compensation relates to this undisclosed information and how difficult it could be for the NEO, or how likely it will be for the company, to achieve the undisclosed performance goal or similar condition.
(b) adding the following subsections:
(5) Disclose whether or not the board of directors, or a committee of the board, considered the implications of the risks associated with the company's compensation policies and practices. If the implications were considered, disclose the following:
(a) the extent and nature of the board of directors' or committee' role in the risk oversight of the company's compensation policies and practices;
(b) any practices the company uses to identify and mitigate compensation policies and practices that could encourage an NEO or individual at a principal business unit or division to take inappropriate or excessive risks;
(c) any identified risks arising from the company's compensation policies and practices that are reasonably likely to have a material adverse effect on the company.
(6) Disclose whether or not an NEO or director is permitted to purchase financial instruments, including, for greater certainty, prepaid variable forward contracts, equity swaps, collars, or units of exchange funds, that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held, directly or indirectly, by the NEO or director.
(c) replacing Commentary 3 with the following:
3. If the company used any benchmarking in determining compensation or any element of compensation, include the benchmark group and describe why the benchmark group and selection criteria are considered by the company to be relevant.
4. The following are examples of items that will usually be significant elements of disclosure concerning compensation:
• contractual or non-contractual arrangements, plans, process changes or any other matters that might cause the amounts disclosed for the most recently completed financial year to be misleading if used as an indicator of expected compensation levels in future periods;
• the process for determining perquisites and personal benefits;
• policies and decisions about the adjustment or recovery of awards, earnings, payments, or payables if the performance goal or similar condition on which they are based are restated or adjusted to reduce the award, earning, payment, or payable;
• the basis for selecting events that trigger payment for any arrangement that provides for payment at, following or in connection with any termination or change of control;
• any waiver or change to any specified performance goal or similar condition to payout for any amount, including whether the waiver or change applied to one or more specified NEOs or to all compensation subject to the performance goal or similar condition;
• whether the board of directors can exercise a discretion, either to award compensation absent attainment of the relevant performance goal or similar condition or to reduce or increase the size of any award or payout, including if they exercised discretion and whether it applied to one or more named executive officers;
• whether the company will be making any significant changes to its compensation policies and practices in the next financial year;
• the role of executive officers in determining executive compensation; and
• performance goals or similar conditions in respect of specific quantitative or qualitative performance-related factors for NEOs.
5. The following are examples of situations that could potentially encourage an executive officer to expose the company to inappropriate or excessive risks:
• compensation policies and practices at a principal business unit of the company or a subsidiary of the company that are structured significantly differently than others within the company;
• compensation policies and practices for certain executive officers that are structured significantly differently than other executive officers within the company;
• compensation policies and practices that do not include effective risk management and regulatory compliance as part of the performance metrics used in determining compensation;
• compensation policies and practices where the compensation expense to executive officers is a significant percentage of the company's revenue;
• compensation policies and practices that vary significantly from the overall compensation structure of the company;
• compensation policies and practices where incentive plan awards are awarded upon accomplishment of a task while the risk to the company from that task extends over a significantly longer period of time;
• compensation policies and practices that contain performance goals or similar conditions that are heavily weighed to short-term rather than long-term objectives;
• incentive plan awards that do not provide a maximum benefit or payout limit to executive officers.
The examples above are not exhaustive and the situations to consider will vary depending upon the nature of the company's business and the company's compensation policies and practices.
6. Section 2.3 of Form 51-102F6 is amended by
(a) replacing the section header with "Share-based and option-based awards",
(b) adding "share-based or"after "grant",
(c) replacing "an"with "a share-based or"after "under which", and
(d) deleting "of option-based awards"after "previous grants".
7. Form 51-102F6 is amended by adding the following after section 2.3:
2.4 Compensation governance
(1) Describe any policies and practices adopted by the board of directors to determine the compensation for the company's directors and executive officers.
(2) If the company has established a compensation committee
(a) disclose the name of each committee member and, in respect of each member, state whether or not the member is independent or not independent;
(b) disclose whether or not one or more of the committee members has any direct experience that is relevant to his or her responsibilities in executive compensation;
(c) describe the skills and experience that enable the committee to make decisions on the suitability of the company's compensation policies and practices; and
(d) describe the responsibilities, powers and operation of the committee.
(3) If a compensation consultant or advisor has, at any time since the company's most recently completed financial year, been retained to assist the board of directors or the compensation committee in determining compensation for any of the company's directors or executive officers
(a) state the name of the consultant or advisor and a summary of the mandate the consultant or advisor has been given;
(b) disclose when the consultant or advisor was originally retained; and
(c) if the consultant or advisor has provided any services to the company, or to its affiliated or subsidiary entities, or to any of its directors or members of management, other than or in addition to compensation services provided for any of the company's directors or executive officers,
(i) state this fact and briefly describe the nature of the work,
(ii) disclose whether the board of directors or compensation committee must pre-approve other services the consultant or advisor, or any of its affiliates, provides to the company at the request of management, and
(d) For each of the two most recently completed financial year, disclose,
(i) under the caption "Executive Compensation-Related Fees", the aggregate fees billed by each consultant or advisor, or any of its affiliates, for services related to determining compensation for any of the company's directors and executive officers, and
(ii) under the caption "All Other Fees", the aggregate fees billed for all other services provided by each consultant or advisor, or any of its affiliates, that are not reported under subparagraph (i) and include a description of the nature of the services comprising the fees disclosed under this category.
Commentary
For section 2.4, a director is independent if he or she would be independent within the meaning of section 1.4 of NI 52-110 Audit Committees.
8. Section 3.1 of Form 51-102F6 is amended by
(a) replacing subsection (5) with the following:
For an award disclosed in column (d) or (e), in a narrative after the table,
(a) describe the methodology used to calculate the fair value of the award on the grant date, disclose the key assumptions and estimates used for each calculation, and explain why the company chose that methodology, and
(b) if the fair value of the award on the grant date is different from the fair value determined in accordance with IFRS 2 Share-based Payment (accounting fair value), state the amount of the difference and explain the reasons for the difference.
(b) in Commentary 2,
(i) replacing "board of directors intended to pay, make payable, award, grant, give or otherwise provide"with "company paid, made payable, awarded, granted, gave or otherwise provided".
(c) in Commentary 3,
(i) replacing "it intends to award or pay"with "to be awarded or paid", and
(ii) replacing "it intends to transfer"with "to be transferred".
(d) in subsection (10), adding the following paragraph:
(i) any company contribution to a personal savings plan like a registered retirement savings plan made on behalf of the NEO.
9. Section 3.3 of Form 51-102F6 is repealed.
10. Section 4.1 of Form 51-102F6 is amended by
(a) in subsection (1), adding column "(h)"entitled "Market or payout value of vested share-based awards not paid out or distributed ($)",
(b) in subsection (3), adding "If the option was granted in a different currency than that reported in the table, include a footnote describing the currency and the exercise or base price." after "each award reported in column (b).", and
(c) adding the following subsection:
(8) In column (h), disclose the aggregate market value or payout value of vested share-based awards that have not yet been paid out or distributed.
11. Section 5.1 of Form 51-102F6 is amended by
(a) in paragraph (4)(a), adding ". For purposes of this calculation, the company must assume that the NEO is eligible to receive payments or benefits at year end" after "most recently completed financial year", and
(b) adding the following after paragraph (4)(b):
Commentary
For purposes of quantifying the annual lifetime benefit payable at the end of the most recently completed financial year in column (c1), the company may calculate the annual lifetime benefit payable as follows:
annual benefits payable at the presumed retirement age used to calculate the closing present value of the defined benefit obligation
X
years of credited service at year end
____________________
years of credited service at the presumed retirement age
The company may calculate the annual lifetime benefit payable in accordance with another formula if the company reasonably believes that it produces a more meaningful calculation of the annual lifetime benefit payable at year end.
12. Section 5.2 of Form 51-102F6 is amended by
(a) in subsection (1),
(i) removing in column (d) "Non-compensatory ($)", and
(ii) in column (d) "Accumulated value at year end ($)", replacing "(e)" with "(d)",
(b) repealing subsection (3),
(c) in subsection (4), replacing "(e)" with "(d)" after "column", and
(d) replacing the Commentary with the following:
1. For pension plans that provide the maximum of: (i) the value of a defined benefit pension; and (ii) the accumulated value of a defined contribution pension, companies should disclose the global value of the pension plan in the defined benefit plans table under section 5.1.
For pension plans that provide the sum of a defined benefit component and a defined contribution component, companies should disclose the respective components of the pension plan. The defined benefit component should be disclosed in the defined benefit plans table under section 5.1 and the defined contribution component should be disclosed in the defined contribution plans table under section 5.2.
2. Any contributions by the company or a subsidiary of the company to a personal savings plan like a registered retirement savings plan made on behalf of the NEO must still be disclosed in column (h) of the summary compensation table, as required by paragraph 3.1(10)(i).
13. Section 6.1 of Form 51-102F6 is amended by adding the following after Commentary 3:
4. A company may disclose estimated incremental payments, payables and benefits that are triggered by, or result from, a scenario described in subsection (1), in a tabular format.
14. This Instrument only applies to documents required to be prepared, filed, delivered or sent under National Instrument 51-102 Continuous Disclosure Obligations for periods relating to financial years ending on or after October 31, 2011.
15. This Instrument comes into force on October 31, 2011.
APPENDIX E
CONSEQUENTIAL AMENDMENTS
Schedule E-1
Amendments to
National Instrument 51-102 Continuous Disclosure Obligations
1. National Instrument 51-102 Continuous Disclosure Obligations is amended by this Instrument.
2. Subsection 9.3.1(1) is replaced by the following:
(1) Subject to Item 8 of Form 51-102F5, if a reporting issuer sends an information circular to a securityholder under paragraph 9.1(2)(a), the issuer must
(a) disclose all compensation paid, payable, awarded, granted, given, or otherwise provided, directly or indirectly, by the issuer, or a subsidiary of the issuer, to each NEO and director, in any capacity, including, for greater certainty, all plan and non-plan compensation, direct or indirect pay, remuneration, economic or financial award, reward, benefit, gift or perquisite paid, payable, awarded, granted, given, or otherwise provided to the NEO or director for services provided, directly or indirectly, to the issuer or a subsidiary of the issuer, and
(b) include detail and discussion of the compensation, and the decision-making process relating to compensation, presented in such a way that it provides a reasonable person, applying reasonable effort, an understanding of
(i) how decisions about NEO and director compensation are made,
(ii) the compensation paid, made payable, awarded, granted, given or otherwise provided to each NEO and director, and
(iii) how specific NEO and director compensation relates to the overall stewardship and governance of the reporting issuer.
3. Subsection 11.6(1) is replaced by the following:
(1) A reporting issuer that does not send to its securityholders an information circular that includes the disclosure required by Item 8 of Form 51-102F5 and that does not file an AIF that includes the executive compensation disclosure required by Item 18 of Form 51-102F2 must
(a) disclose all compensation paid, payable, awarded, granted, given, or otherwise provided, directly or indirectly, by the issuer, or a subsidiary of the issuer, to each NEO and director, in any capacity, including, for greater certainty, all plan and non-plan compensation, direct or indirect pay, remuneration, economic or financial award, reward, benefit, gift or perquisite paid, payable, awarded, granted, given, or otherwise provided to the NEO or director for services provided, directly or indirectly, to the issuer or a subsidiary of the issuer, and
(b) include detail and discussion of the compensation, and the decision-making process relating to compensation, presented in such a way that it provides a reasonable person, applying reasonable effort, an understanding of
(i) how decisions about NEO and director compensation are made,
(ii) the compensation paid, made payable, awarded, granted, given or otherwise provided to each NEO and director, and
(iii) how specific NEO and director compensation relates to the overall stewardship and governance of the reporting issuer.
4. This Instrument comes into force on October 31, 2011.
Schedule E-2
Amendments to National Instrument 58-101 Disclosure of Corporate Governance Practices
1. National Instrument 58-101 Disclosure Corporate Governance Practices is amended by this Instrument.
2. Item 7 of Form 58-101F1 Corporate Governance Disclosure is amended by deleting paragraph (d).
3. The Instruction is amended by adding the following after paragraph (3):
(3.1) Issuers may incorporate disclosure regarding compensation made under Item 7 of this Form by reference to the information required to be included in Form 51-102F6 Statement of Executive Compensation. Clearly identify the information that is incorporated by reference into this Form.
4. This instrument comes into force on October 31, 2011.
Schedule E-3
Amendments to National Instrument 58-101 Disclosure of Corporate Governance Practices
1. National Instrument 58-101 Disclosure of Corporate Governance Practices is amended by this Instrument.
2. The Instruction of Form 58-101F2 Corporate Governance Disclosure (Venture Issuers) is amended by adding the following after paragraph (3):
(3.1) Issuers may incorporate disclosure regarding compensation made under Item 6 of this Form by reference to the information required to be included in Form 51-102F6 Statement of Executive Compensation. Clearly identify the information that is incorporated by reference into this Form.
3. This instrument comes into force on October 31, 2011.
APPENDIX F
LOCAL INFORMATION
Notice of Commission Approval
On July 19, 2011 the Ontario Securities Commission (the Commission) approved the Amended Form 51-102F6 and Consequential Amendments (collectively, the Amendments) pursuant to section 143 of the Securities Act (Ontario) (the Act).
The Amendments have an effective date of October 31, 2011.
Delivery to the Minister
The Amendments together with related materials were delivered to the Minister of Finance on July 21, 2011. The Minister may approve or reject the Amendments or return them for further consideration. If the Minister approves the Amendments or does not take any further action by October 30, 2011, the Amendments will come into force on October 31, 2011.
APPENDIX G
BLACKLINE
FORM 51-102F6
STATEMENT OF EXECUTIVE COMPENSATION
(in respect of financial years ending on or after December 31, 2008)
ITEM 1 - GENERAL PROVISIONS
1.1 Objective
All direct and indirect compensation provided to certain executive officers and directors for, or in connection with, services they have provided to the company or a subsidiary of the company must be disclosed in this form.
The objective of this disclosure is to communicate the compensation the
board of directors intended thecompanyto paypaid,makemade payable,award, grant, giveawarded, granted, gave or otherwiseprovideprovided to each NEO and director for the financial year, and the decision-making process relating to compensation. This disclosure will provide insight into executive compensation as a key aspect of the overall stewardship and governance of the company and will help investors understand how decisions about executive compensation are made.A company's executive compensation disclosure under this form must satisfy this objective and subsections 9.3.1(1) or 11.6(1) of the Instrument.
1.2 Definitions
If a term is used in this form but is not defined in this section, refer to subsection 1.1(1) of the Instrument or to National Instrument 14-101 Definitions.
In this form,
"CEO" means an individual who acted as chief executive officer of the company, or acted in a similar capacity, for any part of the most recently completed financial year;
"CFO" means an individual who acted as chief financial officer of the company, or acted in a similar capacity, for any part of the most recently completed financial year;
"closing market price" means the price at which the company's security was last sold, on the applicable date,
(a) in the security's principal marketplace in Canada, or
(b) if the security is not listed or quoted on a marketplace in Canada, in the security's principal marketplace;
"company" includes other types of business organizations such as partnerships, trusts and other unincorporated business entities;
"equity incentive plan" means an incentive plan, or portion of an incentive plan, under which awards are granted and that falls within the scope of IFRS 2 Share-based Payment;
"external management company" includes a subsidiary, affiliate or associate of the external management company;
"grant date" means a date determined for financial statement reporting purposes under IFRS 2 Share-based Payment;
"incentive plan" means any plan providing compensation that depends on achieving certain performance goals or similar conditions within a specified period;
"incentive plan award" means compensation awarded, earned, paid, or payable under an incentive plan;
"NEO" or "named executive officer" means each of the following individuals:
(a) a CEO;
(b) a CFO;
(c) each of the three most highly compensated executive officers of the company, including any of its subsidiaries, or the three most highly compensated individuals acting in a similar capacity, other than the CEO and CFO, at the end of the most recently completed financial year whose total compensation was, individually, more than $150,000, as determined in accordance with subsection 1.3(6), for that financial year; and
(d) each individual who would be an NEO under paragraph (c) but for the fact that the individual was neither an executive officer of the company or its subsidiaries, nor acting in a similar capacity, at the end of that financial year;
"NI 52-107" [deleted];
"non-equity incentive plan" means an incentive plan or portion of an incentive plan that is not an equity incentive plan;
"option-based award" means an award under an equity incentive plan of options, including, for greater certainty, share options, share appreciation rights, and similar instruments that have option-like features;
"plan" includes any plan, contract, authorization, or arrangement, whether or not set out in any formal document, where cash, securities, similar instruments or any other property may be received, whether for one or more persons;
"replacement grant" means an option that a reasonable person would consider to be granted in relation to a prior or potential cancellation of an option;
"repricing" means, in relation to an option, adjusting or amending the exercise or base price of the option, but excludes any adjustment or amendment that equally affects all holders of the class of securities underlying the option and occurs through the operation of a formula or mechanism in, or applicable to, the option;
"share-based award" means an award under an equity incentive plan of equity-based instruments that do not have option-like features, including, for greater certainty, common shares, restricted shares, restricted share units, deferred share units, phantom shares, phantom share units, common share equivalent units, and stock.
1.3 Preparing the form
(1) All compensation to be included
(a) When completing this form, the company must disclose all compensation paid, payable, awarded, granted, given, or otherwise provided, directly or indirectly, by the company, or a subsidiary of the company, to each NEO and director, in any capacity, including, for greater certainty, all plan and non-plan compensation, direct and indirect pay, remuneration, economic or financial award, reward, benefit, gift or perquisite paid, payable, awarded, granted, given, or otherwise provided to the NEO or director for services provided and for services to be provided, directly or indirectly, to the company or a subsidiary of the company.
(b) Despite paragraph (a), in respect of the Canada Pension Plan, similar government plans, and group life, health, hospitalization, medical reimbursement and relocation plans that do not discriminate in scope, terms or operation and are generally available to all salaried employees, the company is not required to disclose as compensation
(i) any contributions or premiums paid or payable by the company on behalf of an NEO, or of a director, under these plans, and
(ii) any cash, securities, similar instruments or any other property received by an NEO, or by a director, under these plans.
(c) For greater certainty, the plans described in paragraph (b) include plans that provide for such benefits after retirement.
(d) If an item of compensation is not specifically mentioned or described in this form, it is to be disclosed in column (h) ("All other compensation") of the summary compensation table in section 3.1.
(2) Departures from format
(a) Although the required disclosure must be made in accordance with this form, the disclosure may
(
ai) omit a table, column of a table, or other prescribed information, if it does not apply, and(
bii) addtables, columns, anda table, column, or other information, if(A) necessary to satisfy the objective in section
1.1.1.1, and(B) to a reasonable person, the table, column, or other information does not detract from the prescribed information in the summary compensation table in section 3.1.
(b) Despite paragraph (a)(ii), a company must not add a column in the summary compensation table in section 3.1.
(3) Information for full financial year
If an NEO acted in that capacity for the company during part of the financial year for which disclosure is required in the summary compensation table, provide details of all of the compensation that the NEO received from the company for that financial year. This includes compensation the NEO earned in any other position with the company during the financial year.
Do not annualize compensation in a table for any part of a year when an NEO was not in the service of the company. Annualized compensation may be disclosed in a footnote.
(4) External management companies
(a) If one or more individuals acting as an NEO of the company are not employees of the company, disclose the names of those individuals.
(b) If an external management company employs or retains one or more individuals acting as NEOs or directors of the company and the company has entered into an understanding, arrangement or agreement with the external management company to provide executive management services to the company directly or indirectly, disclose any compensation that:
(i) the company paid directly to an individual employed, or retained by the external management company, who is acting as an NEO or director of the company; and
(ii) the external management company paid to the individual that is attributable to the services they provided to the company directly or indirectly.
(c) If an external management company provides the company's executive management services and also provides executive management services to another company, disclose
:
(i) the portion of the compensation paid to the individual acting as an NEO or director that the external management company attributes to services the external management company provided to the company; or (ii)the entire compensation the external management company paid to the individual acting as an NEO or directorin connection with services the external management company provided to the company, the parent or a subsidiary of the company. If the management company allocates the compensation paid to an NEO or director, disclose the basis or methodology used to allocate this compensation.Commentary
An NEO may be employed by an external management company and provide services to the company under an understanding, arrangement or agreement. In this case, references in this form to the CEO or CFO are references to the individuals who performed similar functions to that of the CEO or CFO. They are generally the same individuals who signed and filed annual and interim certificates to comply with National Instrument 52-109 Certification of Disclosure in Issuers' Annual and Interim Filings.
(5) Director and NEO compensation
Disclose any compensation awarded to, earned by, paid to, or payable to each director and NEO, in any capacity with respect to the company. Compensation to directors and NEOs must include all compensation from the company and its subsidiaries.
Disclose any compensation awarded to, earned by, paid to, or payable to, an NEO, or director, in any capacity with respect to the company, by another person or company.
(6) Determining if an individual is an NEO
For the purpose of calculating total compensation awarded to, earned by, paid to, or payable to an individual under paragraph (c) of the definition of NEO,
(a) use the total compensation that would be reported under column (i) of the summary compensation table required by section 3.1 for each executive officer, as if that executive officer were an NEO for the company's most recently completed financial year, and
(b) exclude from the calculation,
(i) any compensation that would be reported under column (g) of the summary compensation table required by section 3.1,
(ii) any incremental payments, payables, and benefits to an executive officer that are triggered by, or result from, a scenario listed in section 6.1 that occurred during the most recently completed financial year, and
(iii) any cash compensation that relates to foreign assignments that is specifically intended to offset the impact of a higher cost of living in the foreign location, and is not otherwise related to the duties the executive officer performs for the company.
Commentary
The $150,000 threshold in paragraph (c) of the definition of NEO only applies when determining who is an NEO in a company's most recently completed financial year. If an individual is an NEO in the most recently completed financial year, disclosure of compensation in prior years must be provided if otherwise required by this form even if total compensation in a prior year is less than $150,000 in that year.
(7) Compensation to associates
Disclose any awards, earnings, payments, or payables to an associate of an NEO, or of a director, as a result of compensation awarded to, earned by, paid to, or payable to the NEO or the director, in any capacity with respect to the company.
(8) New reporting issuers
(a) Subject to paragraph (b) and subsection 3.1(1), disclose information in the summary compensation table for the three most recently completed financial years since the company became a reporting issuer.
(b) Do not provide information for a completed financial year if the company was not a reporting issuer
for any part of thatat any time during the most recently completed financial year, unless the company became a reporting issuer as a result of a restructuring transaction.(c) If the company was not a reporting issuer at any time during the most recently completed financial year and the company is completing the form because it is preparing a prospectus, discuss all significant elements of the compensation to be awarded to, earned by, paid to, or payable to NEOs of the company once it becomes a reporting issuer, to the extent this compensation has been determined.
Commentary
1. Unless otherwise specified, information required to be disclosed under this form may be prepared in accordance with the accounting principles the company uses to prepare its financial statements, as permitted by National Instrument 52-107 Acceptable Accounting Principles and Auditing Standards.
2. The definition of "director" under securities legislation includes an individual who acts in a capacity similar to that of a director.
(9) Currencies
Companies must report amounts required by this form in Canadian dollars or in the same currency that the company uses for its financial statements. A company must use the same currency in the tables in sections 3.1, 4.1, 4.2, 5.1, 5.2 and 7.1 of this form.
If compensation awarded to, earned by, paid to, or payable to an NEO was in a currency other than the currency reported in the prescribed tables of this form, state the currency in which compensation was awarded, earned, paid, or payable, disclose the currency exchange rate and describe the methodology used to translate the compensation into Canadian dollars or the currency that the company uses in its financial statements.
(10) Plain Language
Information required to be disclosed under this form must be clear, concise, and presented in such a way that it provides a reasonable person, applying reasonable effort, an understanding of,
(a) how decisions about NEO and director compensation are made; and
(b) how specific NEO and director compensation relates to the overall stewardship and governance of the company.
Commentary
Refer to the plain language principles listed in section 1.5 of Companion Policy 51-102CP Continuous Disclosure Obligations for further guidance.
ITEM 2 -- COMPENSATION DISCUSSION AND ANALYSIS
2.1 Compensation discussion and analysis
(1) Describe and explain all significant elements of compensation awarded to, earned by, paid to, or payable to NEOs for the most recently completed financial year. Include the following:
(a) the objectives of any compensation program or strategy;
(b) what the compensation program is designed to reward;
(c) each element of compensation;
(d) why the company chooses to pay each element;
(e) how the company determines the amount (and, where applicable, the formula) for each element; and
(f) how each element of compensation and the company's decisions about that element fit into the company's overall compensation objectives and affect decisions about other elements.
(2) If applicable, describe any new actions, decisions or policies that were made after the end of the most recently completed financial year that could affect a reasonable person's understanding of an NEO's compensation for the most recently completed financial year.
(3) If applicable, clearly state the benchmark and explain its components, including the companies included in the benchmark group and the selection criteria.
(4) If applicable, disclose performance goals or similar conditions that are based on objective, identifiable measures, such as the company's share price or earnings per share. If performance goals or similar conditions are subjective, the company may describe the performance goal or similar condition without providing specific measures.
If the company discloses performance goals or similar conditions that are non-GAAP financial measures, explain how the company calculates these performance goals or similar conditions from its financial statements.
Exemption
The company is not required to disclose performance goals or similar conditions in respect of specific quantitative or qualitative performance-related factors if a reasonable person would consider that disclosing them would seriously prejudice the company's interests.
Companies do not qualify for this exemption if they haveFor the purposes of this exemption, a company's interest's are not considered to be seriously prejudiced solely by disclosing performance goals or similar conditions if those goals or conditions are based on broad corporate-level financial performance metrics which include earnings per share, revenue growth, and earnings before interest, taxes, depreciation and amortization.
This exemption does not apply if it has publicly disclosed the performance goals or similar conditions.
If the company is relying on this exemption, state this fact and explain why disclosing the performance goals or similar conditions would seriously prejudice the company's interests.
If the company does not disclose specific performance goals or similar conditions, state what percentage of the NEO's total compensation relates to this undisclosed information and how difficult it could be for the NEO, or how likely it will be for the company, to achieve the undisclosed performance goal or similar condition.
If the company discloses performance goals or similar conditions that are non-GAAP financial measures, explain how the company calculates these performance goals or similar conditions from its financial statements.(5) Disclose whether or not the board of directors, or a committee of the board, considered the implications of the risks associated with the company's compensation policies and practices. If the implications were considered, disclose the following:
(a) the extent and nature of the board of directors' or committee' role in the risk oversight of the company's compensation policies and practices;
(b) any practices the company uses to identify and mitigate compensation policies and practices that could encourage an NEO or individual at a principal business unit or division to take inappropriate or excessive risks;
(c) any identified risks arising from the company's compensation policies and practices that are reasonably likely to have a material adverse effect on the company.
(6) Disclose whether or not an NEO or director is permitted to purchase financial instruments, including, for greater certainty, prepaid variable forward contracts, equity swaps, collars, or units of exchange funds, that are designed to hedge or offset a decrease in market value of equity securities granted as compensation or held, directly or indirectly, by the NEO or director.
Commentary
1. The information disclosed under section 2.1 will depend on the facts. Provide enough analysis to allow a reasonable person, applying reasonable effort, to understand the disclosure elsewhere in this form. Describe the significant principles underlying policies and explain the decisions relating to compensation provided to an NEO. Disclosure that merely describes the process for determining compensation or compensation already awarded, earned, paid, or payable is not adequate. The information contained in this section should give readers a sense of how compensation is tied to the NEO's performance. Avoid boilerplate language.
2. If the company's process for determining executive compensation is very simple, for example, the company relies solely on board discussion without any formal objectives, criteria and analysis, then make this clear in the discussion.
3. If the company used any benchmarking in determining compensation or any element of compensation, include the benchmark group and describe why the benchmark group and selection criteria are considered by the company to be relevant.
4. The following are examples of items that will usually be significant elements of disclosure concerning compensation:
• contractual or non-contractual arrangements, plans, process changes or any other matters that might cause the amounts disclosed for the most recently completed financial year to be misleading if used as an indicator of expected compensation levels in future periods;
• the process for determining perquisites and personal benefits;
• policies and decisions about the adjustment or recovery of awards, earnings, payments, or payables if the performance goal or similar condition on which they are based are restated or adjusted to reduce the award, earning, payment, or payable;
• the basis for selecting events that trigger payment for any arrangement that provides for payment at, following or in connection with any termination or change of control;
• whether the company used any benchmarking in determining compensation or any element of compensation;• any waiver or change to any specified performance goal or similar condition to payout for any amount, including whether the waiver or change applied to one or more specified NEOs or to all compensation subject to the performance goal or similar condition;
• whether the board of directors can exercise a discretion, either to award compensation absent attainment of the relevant performance goal or similar condition or to reduce or increase the size of any award or payout, including if they exercised discretion and whether it applied to one or more named executive officers;
• whether the company will be making any significant changes to its compensation policies and practices in the next financial year;
• the role of executive officers in determining executive compensation; and
• performance goals or similar conditions in respect of specific quantitative or qualitative performance-related factors for NEOs.
5. The following are examples of situations that could potentially encourage an executive officer to expose the company to inappropriate or excessive risks:
• compensation policies and practices at a principal business unit of the company or a subsidiary of the company that are structured significantly differently than others within the company;
• compensation policies and practices for certain executive officers that are structured significantly differently than other executive officers within the company;
• compensation policies and practices that do not include effective risk management and regulatory compliance as part of the performance metrics used in determining compensation;
• compensation policies and practices where the compensation expense to executive officers is a significant percentage of the company's revenue;
• compensation policies and practices that vary significantly from the overall compensation structure of the company;
• compensation policies and practices where incentive plan awards are awarded upon accomplishment of a task while the risk to the company from that task extends over a significantly longer period of time;
• compensation policies and practices that contain performance goals or similar conditions that are heavily weighed to short-term rather than long-term objectives;
• incentive plan awards that do not provide a maximum benefit or payout limit to executive officers.
The examples above are not exhaustive and the situations to consider will vary depending upon the nature of the company's business and the company's compensation policies and practices.
2.2 Performance graph
(a) This section does not apply to
(i) venture issuers,
(ii) companies that have distributed only debt securities or non-convertible, non-participating preferred securities to the public, and
(iii) companies that were not reporting issuers in any jurisdiction in Canada for at least 12 calendar months before the end of their most recently completed financial year, other than companies that became new reporting issuers as a result of a restructuring transaction.
(b) Provide a line graph showing the company's cumulative total shareholder return over the five most recently completed financial years. Assume that $100 was invested on the first day of the five-year period. If the company has been a reporting issuer for less than five years, use the period that the company has been a reporting issuer.
Compare this to the cumulative total return of at least one broad equity market index that, to a reasonable person, would be an appropriate reference point for the company's return. If the company is included in the S&P/TSX Composite Total Return Index, use that index. In all cases, assume that dividends are reinvested.
Discuss how the trend shown by this graph compares to the trend in the company's compensation to executive officers reported under this form over the same period.
Commentary
For section 2.2, companies may also include other relevant performance goals or similar conditions.
2.3
OptionShare-based and option-based awardsDescribe the process the company uses to grant share-based or option-based awards to executive officers. Include the role of the compensation committee and executive officers in setting or amending any equity incentive plan under which
ana share-based or option-based award is granted. State whether previous grantsof option-based awardsare taken into account when considering new grants.2.4 Compensation governance
(1) Describe any policies and practices adopted by the board of directors to determine the compensation for the company's directors and executive officers.
(2) If the company has established a compensation committee
(a) disclose the name of each committee member and, in respect of each member, state whether or not the member is independent or not independent;
(b) disclose whether or not one or more of the committee members has any direct experience that is relevant to his or her responsibilities in executive compensation;
(c) describe the skills and experience that enable the committee to make decisions on the suitability of the company's compensation policies and practices; and
(d) describe the responsibilities, powers and operation of the committee.
(3) If a compensation consultant or advisor has, at any time since the company's most recently completed financial year, been retained to assist the board of directors or the compensation committee in determining compensation for any of the company's directors or executive officers
(a) state the name of the consultant or advisor and a summary of the mandate the consultant or advisor has been given;
(b) disclose when the consultant or advisor was originally retained; and
(c) if the consultant or advisor has provided any services to the company, or to its affiliated or subsidiary entities, or to any of its directors or members of management, other than or in addition to compensation services provided for any of the company's directors or executive officers,
(i) state this fact and briefly describe the nature of the work,
(ii) disclose whether the board of directors or compensation committee must pre-approve other services the consultant or advisor, or any of its affiliates, provides to the company at the request of management, and
(d) For each of the two most recently completed financial year, disclose,
(i) under the caption "Executive Compensation-Related Fees", the aggregate fees billed by each consultant or advisor, or any of its affiliates, for services related to determining compensation for any of the company's directors and executive officers, and
(ii) under the caption "All Other Fees", the aggregate fees billed for all other services provided by each consultant or advisor, or any of its affiliates, that are not reported under subparagraph (i) and include a description of the nature of the services comprising the fees disclosed under this category.
Commentary
For section 2.4, a director is independent if he or she would be independent within the meaning of section 1.4 of NI 52-110 Audit Committees.
ITEM 3 -- SUMMARY COMPENSATION TABLE
3.1 Summary compensation table
(1) For each NEO in the most recently completed financial year, complete this table for each of the company's three most recently completed financial years that end on or after December 31, 2008.
Name and principal position
Year
Salary ($)
Share-based awards ($)
Option-based awards ($)
Non-equity incentive plan compensation ($)
Pension value ($)
All other compensation ($)
Total compensation ($)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
(i)
Annual incentive plans
Long-term incentive plans
(f1)
(f2)
CEO
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
CFO
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
A
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
B
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
C
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
_____
Commentary
Under subsection (1), a company is not required to disclose comparative period disclosure in accordance with the requirements of either Form 51-102F6 Statement of Executive Compensation, which came into force on March 30, 2004, as amended, or this form, in respect of a financial year ending before December 31, 2008.
(2) In column (c), include the dollar value of cash and non-cash base salary an NEO earned during a financial year covered in the table (a covered financial year). If the company cannot calculate the amount of salary earned in a financial year, disclose this in a footnote, along with the reason why it cannot be determined. Restate the salary figure the next time the company prepares this form, and explain what portion of the restated figure represents an amount that the company could not previously calculate.
(3) In column (d), disclose the dollar amount based on the fair value of the award on the grant date for a covered financial year.
(4) In column (e), disclose the dollar amount based on the fair value of the award on the grant date for a covered financial year. Include option-based awards both with or without tandem share appreciation rights.
(5) For an award disclosed in column (d) or (e), in a footnote to the table
or in a narrative after the table,(a) describe the methodology used to calculate the fair value of the award on the grant date, disclose the key assumptions and estimates used for each calculation, and explain why the company chose that methodology, and
(b) if the fair value of the award on the grant date is different from the fair value determined in accordance with IFRS 2 Share-based Payment (accounting fair value), state the amount of the difference and explain the reasons for the difference
, and(b) describe the methodology used to calculate the grant date fair value, disclose the key assumptions and estimates used for each calculation, and explain why the company chose that methodology.Commentary
1. This commentary applies to subsections (3), (4) and (5).
2. The value disclosed in columns (d) and (e) of the summary compensation table should reflect what the
board of directors intended to pay, makecompany paid, made payable,award, grant, giveawarded, granted, gave or otherwiseprovideprovided as compensation on the grant date (fair value of the award) as set out in comment 3, below. This value might differ from the value reported in the issuer's financial statements.3. While compensation practices vary, there are generally two approaches that boards of directors use when setting compensation. A board of directors may decide the value in securities of the company
it intendstoawardbe awarded orpaypaid as compensation. Alternatively, a board of directors may decide the portion of the potential ownership of the companyit intends to transferto be transferred as compensation. A fair value ascribed to the award will normally result from these approaches.A company may calculate this value either in accordance with a valuation methodology identified in IFRS 2 Share-based Payment or in accordance with another methodology set out in comment 5 below.
4. In some cases, the fair value of the award disclosed in columns (d) and (e) might differ from the accounting fair value. For financial statement purposes, the accounting fair value amount is amortized over the service period to obtain an accounting cost (accounting compensation expense), adjusted at year end as required.
5. While the most commonly used methodologies for calculating the value of most types of awards are the Black-Scholes-Merton model and the binomial lattice model, companies may choose to use another valuation methodology if it produces a more meaningful and reasonable estimate of fair value.
6. The summary compensation table requires disclosure of an amount even if the accounting compensation expense is zero. The amount disclosed in the table should reflect the fair value of the award following the principles described under comments 2 and 3, above.
7. Column (d) includes common shares, restricted shares, restricted share units, deferred share units, phantom shares, phantom share units, common share equivalent units, stock, and similar instruments that do not have option-like features.
(6) In column (e), include the incremental fair value if, at any time during the covered financial year, the company has adjusted, amended, cancelled, replaced or significantly modified the exercise price of options previously awarded to, earned by, paid to, or payable to, an NEO. The repricing or modification date must be determined in accordance with IFRS 2Share-based Payment. The methodology used to calculate the incremental fair value must be the same methodology used to calculate the initial grant.
This requirement does not apply to any repricing that equally affects all holders of the class of securities underlying the options and that occurs through a pre-existing formula or mechanism in the plan or award that results in the periodic adjustment of the option exercise or base price, an antidilution provision in a plan or award, or a recapitalization or similar transaction.
(7) Include a footnote to the table quantifying the incremental fair value of any adjusted, amended, cancelled, replaced or significantly modified options that are included in the table.
(8) In column (f), include the dollar value of all amounts earned for services performed during the covered financial year that are related to awards under non-equity incentive plans and all earnings on any such outstanding awards.
(a) If the relevant performance goal or similar condition was satisfied during a covered financial year (including for a single year in a plan with a multi-year performance goal or similar condition), report the amounts earned for that financial year, even if they are payable at a later date. The company is not required to report these amounts again in the summary compensation table when they are actually paid to an NEO.
(b) Include a footnote describing and quantifying all amounts earned on non-equity incentive plan compensation, whether they were paid during the financial year, were payable but deferred at the election of an NEO, or are payable by their terms at a later date.
(c) Include any discretionary cash awards, earnings, payments, or payables that were not based on pre-determined performance goals or similar conditions that were communicated to an NEO. Report any performance-based plan awards that include pre-determined performance goals or similar conditions in column (f).
(d) In column (f1), include annual non-equity incentive plan compensation, such as bonuses and discretionary amounts. For column (f1), annual non-equity incentive plan compensation relates only to a single financial year. In column (f2), include all non-equity incentive plan compensation related to a period longer than one year.
(9) In column (g), include all compensation relating to defined benefit or defined contribution plans. These include service costs and other compensatory items such as plan changes and earnings that are different from the estimated earnings for defined benefit plans and above-market earnings for defined contribution plans.
This disclosure relates to all plans that provide for the payment of pension plan benefits. Use the same amounts included in column (e) of the defined benefit plan table required by Item 5 for the covered financial year and the amounts included in column (c) of the defined contribution plan table as required by Item 5 for the covered financial year.
(10) In column (h), include all other compensation not reported in any other column of this table. Column (h) must include, but is not limited to:
(a) perquisites, including property or other personal benefits provided to an NEO that are not generally available to all employees, and that in aggregate are worth $50,000 or more, or are worth 10% or more of an NEO's total salary for the financial year. Value these items on the basis of the aggregate incremental cost to the company and its subsidiaries. Describe in a footnote the methodology used for computing the aggregate incremental cost to the company.
State the type and amount of each perquisite the value of which exceeds 25% of the total value of perquisites reported for an NEO in a footnote to the table. Provide the footnote information for the most recently completed financial year only;
(b) other post-retirement benefits such as health insurance or life insurance after retirement;
(c) all "gross-ups" or other amounts reimbursed during the covered financial year for the payment of taxes;
(d) the incremental payments, payables, and benefits to an NEO that are triggered by, or result from, a scenario listed in section 6.1 that occurred before the end of the covered financial year;
(e) the dollar value of any insurance premiums paid or payable by, or on behalf of, the company during the covered financial year for personal insurance for an NEO if the estate of the NEO is the beneficiary;
(f) the dollar value of any dividends or other earnings paid or payable on share-based or option-based awards that were not factored into the fair value of the award on the grant date required to be reported in columns (d) and (e);
(g) any compensation cost for any security that the NEO bought from the company or its subsidiaries at a discount from the market price of the security (through deferral of salary, bonus or otherwise). Calculate this cost at the date of purchase and in accordance with IFRS 2Share-based Payment;
and(h) above-market or preferential earnings on compensation that is deferred on a basis that is not tax exempt other than for defined contribution plans covered in the defined contribution plan table in Item 5. Above-market or preferential applies to non-registered plans and means a rate greater than the rate ordinarily paid by the company or its subsidiary on securities or other obligations having the same or similar features issued to third parties; and
(i) any company contribution to a personal savings plan like a registered retirement savings plan made on behalf of the NEO.
Commentary
1. Generally, there will be no incremental payments, payables, and benefits that are triggered by, or result from, a scenario described in section 6.1 that occurred before the end of a covered financial year for compensation that has been reported in the summary compensation table for the most recently completed financial year or for a financial year before the most recently completed financial year.
If the vesting or payout of the previously reported compensation is accelerated, or a performance goal or similar condition in respect of the previously reported compensation is waived, as a result of a scenario described in section 6.1, the incremental payments, payables, and benefits should include the value of the accelerated benefit or of the waiver of the performance goal or similar condition.
2. Generally, an item is not a perquisite if it is integrally and directly related to the performance of an executive officer's duties. If something is necessary for a person to do his or her job, it is integrally and directly related to the job and is not a perquisite, even if it also provides some amount of personal benefit.
If the company concludes that an item is not integrally and directly related to performing the job, it may still be a perquisite if the item provides an NEO with any direct or indirect personal benefit. If it does provide a personal benefit, the item is a perquisite, whether or not it is provided for a business reason or for the company's convenience, unless it is generally available on a non-discriminatory basis to all employees.
Companies must conduct their own analysis of whether a particular item is a perquisite. The following are examples of things that are often considered perquisites or personal benefits. This list is not exhaustive:
• Cars, car lease and car allowance;
• Corporate aircraft or personal travel financed by the company;
• Jewellery;
• Clothing;
• Artwork ;
• Housekeeping services;
• Club membership;
• Theatre tickets;
• Financial assistance to provide education to children of executive officers;
• Parking;
• Personal financial or tax advice;
• Security at personal residence or during personal travel; and
• Reimbursements of taxes owed with respect to perquisites or other personal benefit.
(11) In column (i), include the dollar value of total compensation for the covered financial year. For each NEO, this is the sum of the amounts reported in columns (c) through (h).
(12) Any deferred amounts must be included in the appropriate column for the covered financial year in which they are earned.
(13) If an NEO elected to exchange any compensation awarded to, earned by, paid to, or payable to the NEO in a covered financial year under a program that allows the NEO to receive awards, earnings, payments, or payables in another form, the compensation the NEO elected to exchange must be reported as compensation in the column appropriate for the form of compensation exchanged: Do not report it in the form in which it was or will be received by the NEO. State in a footnote the form of awards, earnings, payments, or payables substituted for the compensation the NEO elected to exchange.
3.2 Narrative discussion
Describe and explain any significant factors necessary to understand the information disclosed in the summary compensation table required by section 3.1.
Commentary
The significant factors described in section 3.2 will vary depending on the circumstances of each award but may include:
• the significant terms of each NEO's employment agreement or arrangement;
• any repricing or other significant changes to the terms of any share-based or option-based award program during the most recently completed financial year; and
• the significant terms of any award reported in the summary compensation table, including a general description of the formula or criterion to be applied in determining the amounts payable and the vesting schedule. For example, if dividends will be paid on shares, state this, the applicable dividend rate and whether that rate is preferential.
3.3
Currencies[deleted]
Report amounts in this form using the same currency that the company uses in its financial statements. If compensation awarded to, earned by, paid to, or payable to an NEO was in a currency other than the presentation currency, state in a footnote the currency in which compensation was awarded, earned, paid, or payable, disclose the translation rate and describe the methodology used to translate the compensation into the presentation currency.3.4 Officers who also act as directors
If an NEO is also a director who receives compensation for services as a director, include that compensation in the summary compensation table and include a footnote explaining which amounts relate to the director role. Do not provide disclosure for that NEO under Item 7.
ITEM 4 - INCENTIVE PLAN AWARDS
4.1 Outstanding share-based awards and option-based awards
(1) Complete this table for each NEO for all awards outstanding at the end of the most recently completed financial year. This includes awards granted before the most recently completed financial year. For all awards in this table, disclose the awards that have been transferred at other than fair market value.
Option-based Awards
Share-based Awards
Name
Number of securities underlying unexercised options (#)
Option exercise price ($)
Option expiration date
Value of unexercised in-the-money options ($)
Number of shares or units of shares that have not vested (#)
Market or payout value of share-based awards that have not vested ($)
<<Market or payout value of vested share-based awards not paid out or distributed ($)>>
(a)
(b)
(c)
(d)
(e)
(f)
(g)
<<(h)>>
CEO
_____
_____
_____
_____
_____
_____
_____
CFO
_____
_____
_____
_____
_____
_____
_____
A
_____
_____
_____
_____
_____
_____
_____
B
_____
_____
_____
_____
_____
_____
_____
C
_____
_____
_____
_____
_____
_____
_____
(2) In column (b), for each award, disclose the number of securities underlying unexercised options.
(3) In column (c), disclose the exercise or base price for each option under each award reported in column (b).If the option was granted in a different currency than that reported in the table, include a footnote describing the currency and the exercise or base price.
(4) In column (d), disclose the expiration date for each option under each award reported in column (b).
(5) In column (e), disclose the aggregate dollar amount of in-the-money unexercised options held at the end of the year. Calculate this amount based on the difference between the market value of the securities underlying the instruments at the end of the year, and the exercise or base price of the option.
(6) In column (f), disclose the total number of shares or units that have not vested.
(7) In column (g), disclose the aggregate market value or payout value of share-based awards that have not vested.
If the share-based award provides only for a single payout on vesting, calculate this value based on that payout.
If the share-based award provides for different payouts depending on the achievement of different performance goals or similar conditions, calculate this value based on the minimum payout. However, if the NEO achieved a performance goal or similar condition in a financial year covered by the share-based award that on vesting could provide for a payout greater than the minimum payout, calculate this value based on the payout expected as a result of the NEO achieving this performance goal or similar condition.
(8) In column (h), disclose the aggregate market value or payout value of vested share-based awards that have not yet been paid out or distributed.
4.2 Incentive plan awards - value vested or earned during the year
(1) Complete this table for each NEO for the most recently completed financial year.
Name
Option-based awards -- Value vested during the year ($)
Share-based awards -- Value vested during the year ($)
Non-equity incentive plan compensation - Value earned during the year ($)
(a)
(b)
(c)
(d)
CEO
__________
__________
__________
CFO
__________
__________
__________
A
__________
__________
__________
B
__________
__________
__________
C
__________
__________
__________
(2) In column (b), disclose the aggregate dollar value that would have been realized if the options under the option-based award had been exercised on the vesting date. Compute the dollar value that would have been realized by determining the difference between the market price of the underlying securities at exercise and the exercise or base price of the options under the option-based award on the vesting date. Do not include the value of any related payment or other consideration provided (or to be provided) by the company to or on behalf of an NEO.
(3) In column (c), disclose the aggregate dollar value realized upon vesting of share-based awards. Compute the dollar value realized by multiplying the number of shares or units by the market value of the underlying shares on the vesting date. For any amount realized upon vesting for which receipt has been deferred, include a footnote that states the amount and the terms of the deferral.
4.3 Narrative discussion
Describe and explain the significant terms of all plan-based awards, including non-equity incentive plan awards, issued or vested, or under which options have been exercised, during the year, or outstanding at the year end, to the extent not already discussed under sections 2.1, 2.3 and 3.2. The company may aggregate information for different awards, if separate disclosure of each award is not necessary to communicate their significant terms.
Commentary
The items included in the narrative required by section 4.3 will vary depending on the terms of each plan, but may include:
• the number of securities underlying each award or received on vesting or exercise;
• general descriptions of formulae or criteria that are used to determine amounts payable;
• exercise prices and expiry dates;
• dividend rates on share-based awards;
• whether awards are vested or unvested;
• performance goals or similar conditions, or other significant conditions;
• information on estimated future payouts for non-equity incentive plan awards (performance goals or similar conditions and maximum amounts); and
• the closing market price on the grant date, if the exercise or base price is less than the closing market price of the underlying security on the grant date.
ITEM 5 - PENSION PLAN BENEFITS
5.1 Defined benefit plans table
(1) Complete this table for all pension plans that provide for payments or benefits at, following, or in connection with retirement, excluding defined contribution plans. For all disclosure in this table, use the same assumptions and methods used for financial statement reporting purposes under the accounting principles used to prepare the company's financial statements, as permitted by National Instrument 52-107Acceptable Accounting Principles and Auditing Standards.
Name
Number of years credited service (#)
Annual benefits payable ($)
Opening Present value of defined benefit obligation ($)
Compensatory change ($)
Non-compensatory change ($)
Closing present value of defined benefit obligation ($)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
At year end
At age 65
(c1)
(c2)
CEO
_____
_____
_____
_____
_____
_____
_____
CFO
_____
_____
_____
_____
_____
_____
_____
A
_____
_____
_____
_____
_____
_____
_____
B
_____
_____
_____
_____
_____
_____
_____
C
_____
_____
_____
_____
_____
_____
_____
(2) In columns (b) and (c), the disclosure must be as of the end of the company's most recently completed financial year. In columns (d) through (g), the disclosure must be as of the reporting date used in the company's audited financial statements for the most recently completed financial year.
(3) In column (b), disclose the number of years of service credited to an NEO under the plan. If the number of years of credited service in any plan is different from the NEO's number of actual years of service with the company, include a footnote that states the amount of the difference and any resulting benefit augmentation, such as the number of additional years the NEO received.
(4) In column (c), disclose
(a) the annual lifetime benefit payable at the end of the most recently completed financial year in column (c1) based on years of credited service reported in column (b) and actual pensionable earnings as at the end of the most recently completed financial year. For purposes of this calculation, the company must assume that the NEO is eligible to receive payments or benefits at year end, and
(b) the annual lifetime benefit payable at age 65 in column (c2) based on years of credited service as of age 65 and actual pensionable earnings through the end of the most recently completed financial year, as per column (c1).
Commentary
For purposes of quantifying the annual lifetime benefit payable at the end of the most recently completed financial year in column (c1), the company may calculate the annual lifetime benefit payable as follows:
<<annual benefits payable at the presumed retirement age used to calculate the closing present value of the defined benefit obligation>>
<<X>>
<<years of credited service at year end>>
____________________
<<years of credited service at the presumed retirement age>>
The company may calculate the annual lifetime benefit payable in accordance with another formula if the company reasonably believes that it produces a more meaningful calculation of the annual lifetime benefit payable at year end.
(5) In column (d), disclose the present value of the defined benefit obligation at the start of the most recently completed financial year.
(6) In column (e), disclose the compensatory change in the present value of the defined benefit obligation for the most recently completed financial year. This includes service cost net of employee contributions plus plan changes and differences between actual and estimated earnings, and any additional changes that have retroactive impact, including, for greater certainty, a change in valuation assumptions as a consequence of an amendment to benefit terms.
Disclose the valuation method and all significant assumptions the company applied in quantifying the closing present value of the defined benefit obligation. The company may satisfy all or part of this disclosure by referring to the disclosure of assumptions in its financial statements, footnotes to the financial statements or discussion in its management's discussion and analysis.
(7) In column (f), disclose the non-compensatory changes in the present value of the defined benefit obligation for the company's most recently completed financial year. Include all items that are not compensatory, such as changes in assumptions other than those already included in column (e) because they were made as a consequence of an amendment to benefit terms, employee contributions and interest on the present value of the defined benefit obligation at the start of the most recently completed financial year.
(8) In column (g), disclose the present value of the defined benefit obligation at the end of the most recently completed financial year.
5.2 Defined contribution plans table
(1) Complete this table for all pension plans that provide for payments or benefits at, following or in connection with retirement, excluding defined benefit plans. For all disclosure in this table, use the same assumptions and methods used for financial statement reporting purposes under the accounting principles used to prepare the company's financial statements, as permitted by National Instrument 52-107Acceptable Accounting Principles and Auditing Standards.
Name
Accumulated value at start of year ($)
Compensatory ($)
Non-compensatory ($)Accumulated value at year end ($)
(a)
(b)
(c)
(d)
(e)<<(d)>>
CEO
_____
_____
_____
_____
CFO
_____
_____
_____
_____
A
_____
_____
_____
_____
B
_____
_____
_____
_____
C
_____
_____
_____
_____
(2) In column (c), disclose the employer contribution and above-market or preferential earnings credited on employer and employee contributions. Above-market or preferential earnings applies to non-registered plans and means a rate greater than the rate ordinarily paid by the company or its subsidiary on securities or other obligations having the same or similar features issued to third parties.
(3) In column (d), disclose the non-compensatory amount, including employee contributions and regular investment earnings on employer and employee contributions. Regular investment earnings means all investment earnings in registered defined contribution plans and earnings that are not above market or preferential in other defined contribution plans.(3) [Deleted]
(4) In column (
ed), disclose the accumulated value at the end of the most recently completed financial year.Commentary
1. For pension plans that provide the maximum of: (i) the value of a defined benefit pension; and (ii) the accumulated value of a defined contribution pension, companies should disclose the global value of the pension plan in the defined benefit plans table under section 5.1.
For pension plans that provide the sum of a defined benefit component and a defined contribution component, companies should disclose the respective components of the pension plan. The defined benefit component should be disclosed in the defined benefit plans table under section 5.1 and the defined contribution component should be disclosed in the defined contribution plans table under section 5.2.
2. Any contributions by the company or a subsidiary of the company to a personal savings plan like a registered retirement savings plan made on behalf of the NEO must still be disclosed in column (h) of the summary compensation table, as required by paragraph 3.1(10)(i).
5.3 Narrative discussion
Describe and explain for each retirement plan in which an NEO participates, any significant factors necessary to understand the information disclosed in the defined benefit plan table in section 5.1 and the defined contribution plan table in section 5.2.
Commentary
Significant factors described in the narrative required by section 5.3 will vary, but may include:
• the significant terms and conditions of payments and benefits available under the plan, including the plan's normal and early retirement payment, benefit formula, contribution formula, calculation of interest credited under the defined contribution plan and eligibility standards;
• provisions for early retirement, if applicable, including the name of the NEO and the plan, the early retirement payment and benefit formula and eligibility standards. Early retirement means retirement before the normal retirement age as defined in the plan or otherwise available under the plan;
• the specific elements of compensation (e.g., salary, bonus) included in applying the payment and benefit formula. If a company provides this information, identify each element separately; and
• company policies on topics such as granting extra years of credited service, including an explanation of who these arrangements relate to and why they are considered appropriate.
5.4 Deferred compensation plans
Describe the significant terms of any deferred compensation plan relating to each NEO, including:
(a) the types of compensation that can be deferred and any limitations on the extent to which deferral is permitted (by percentage of compensation or otherwise);
(b) significant terms of payouts, withdrawals and other distributions; and
(c) measures for calculating interest or other earnings, how and when these measures may be changed, and whether an NEO or the company chose these measures. Quantify these measures wherever possible.
ITEM 6 -- TERMINATION AND CHANGE OF CONTROL BENEFITS
6.1 Termination and change of control benefits
(1) For each contract, agreement, plan or arrangement that provides for payments to an NEO at, following or in connection with any termination (whether voluntary, involuntary or constructive), resignation, retirement, a change in control of the company or a change in an NEO's responsibilities, describe, explain, and where appropriate, quantify the following items:
(a) the circumstances that trigger payments or the provision of other benefits, including perquisites and pension plan benefits;
(b) the estimated incremental payments, payables, and benefits that are triggered by, or result from, each circumstance, including timing, duration and who provides the payments and benefits;
(c) how the payment and benefit levels are determined under the various circumstances that trigger payments or provision of benefits;
(d) any significant conditions or obligations that apply to receiving payments or benefits. This includes but is not limited to, non-compete, non-solicitation, non-disparagement or confidentiality agreements. Include the term of these agreements and provisions for waiver or breach; and
(e) any other significant factors for each written contract, agreement, plan or arrangement.
(2) Disclose the estimated incremental payments, payables, and benefits even if it is uncertain what amounts might be paid in given circumstances under the various plans and arrangements, assuming that the triggering event took place on the last business day of the company's most recently completed financial year. For valuing share-based awards or option-based awards, use the closing market price of the company's securities on that date.
If the company is unsure about the provision or amount of payments or benefits, make a reasonable estimate (or a reasonable estimate of the range of amounts) and disclose the significant assumptions underlying these estimates.
(3) Despite subsection (1), the company is not required to disclose the following:
(a) Perquisites and other personal benefits if the aggregate of this compensation is less than $50,000. State the individual perquisites and personal benefits as required by paragraph 3.1(10)(a).
(b) Information about possible termination scenarios for an NEO whose employment terminated in the past year. The company must only disclose the consequences of the actual termination.
(c) Information in respect of a scenario described in subsection (1) if there will be no incremental payments, payables, and benefits that are triggered by, or result from, that scenario.
Commentary
1. Subsection (1) does not require the company to disclose notice of termination without cause, or compensation in lieu thereof, which are implied as a term of an employment contract under common law or civil law.
2. Item 6 applies to changes of control regardless of whether the change of control results in termination of employment.
3. Generally, there will be no incremental payments, payables, and benefits that are triggered by, or result from, a scenario described in subsection (1) for compensation that has been reported in the summary compensation table for the most recently completed financial year or for a financial year before the most recently completed financial year.
If the vesting or payout of the previously reported compensation is accelerated, or a performance goal or similar condition in respect of the previously reported compensation is waived, as a result of a scenario described in subsection (1), the incremental payments, payables, and benefits should include the value of the accelerated benefit or of the waiver of the performance goal or similar condition.
4. A company may disclose estimated incremental payments, payables and benefits that are triggered by, or result from, a scenario described in subsection (1), in a tabular format.
ITEM 7 - DIRECTOR COMPENSATION
7.1 Director compensation table
(1) Complete this table for all amounts of compensation provided to the directors for the company's most recently completed financial year.
Name
Fees earned ($)
Share-based awards ($)
Option-based awards ($)
Non-equity incentive plan compensation ($)
Pension value ($)
All other compensation ($)
Total ($)
(a)
(b)
(c)
(d)
(e)
(f)
(g)
(h)
A
_____
_____
_____
_____
_____
_____
_____
B
_____
_____
_____
_____
_____
_____
_____
C
_____
_____
_____
_____
_____
_____
_____
D
_____
_____
_____
_____
_____
_____
_____
E
_____
_____
_____
_____
_____
_____
_____
(2) All forms of compensation must be included in this table.
(3) Complete each column in the manner required for the corresponding column in the summary compensation table in section 3.1, in accordance with the requirements of Item 3, as supplemented by the commentary to Item 3, except as follows:
(a) In column (a), do not include a director who is also an NEO if his or her compensation for service as a director is fully reflected in the summary compensation table and elsewhere in this form. If an NEO is also a director who receives compensation for his or her services as a director, reflect the director compensation in the summary compensation table required by section 3.1 and provide a footnote to this table indicating that the relevant disclosure has been provided under section 3.4.
(b) In column (b), include all fees awarded, earned, paid, or payable in cash for services as a director, including annual retainer fees, committee, chair, and meeting fees.
(c) In column (g), include all compensation paid, payable, awarded, granted, given, or otherwise provided, directly or indirectly, by the company, or a subsidiary of the company, to a director in any capacity, under any other arrangement. This includes, for greater certainty, all plan and non-plan compensation, direct and indirect pay, remuneration, economic or financial award, reward, benefit, gift or perquisite paid, payable, awarded, granted, given, or otherwise provided to the director for services provided, directly or indirectly, to the company or a subsidiary of the company. In a footnote to the table, disclose these amounts and describe the nature of the services provided by the director that are associated with these amounts.
(d) In column (g), include programs where the company agrees to make donations to one or more charitable institutions in a director's name, payable currently or upon a designated event such as the retirement or death of the director. Include a footnote to the table disclosing the total dollar amount payable under the program.
7.2 Narrative discussion
Describe and explain any factors necessary to understand the director compensation disclosed in section 7.1.
Commentary
Significant factors described in the narrative required by section 7.2 will vary, but may include:
• disclosure for each director who served in that capacity for any part of the most recently completed financial year;
• standard compensation arrangements, such as fees for retainer, committee service, service as chair of the board or a committee, and meeting attendance;
• any compensation arrangements for a director that are different from the standard arrangements, including the name of the director and a description of the terms of the arrangement; and
• any matters discussed in the compensation discussion and analysis that do not apply to directors in the same way that they apply to NEOs such as practices for granting option-based awards.
7.3 Share-based awards, option-based awards and non-equity incentive plan compensation
Provide the same disclosure for directors that is required under Item 4 for NEOs.
ITEM 8 - COMPANIES REPORTING IN THE UNITED STATES
8.1 Companies reporting in the United States
(1) Except as provided in subsection (2), SEC issuers may satisfy the requirements of this form by providing the information required by Item 402 "Executive compensation" of Regulation S-K under the 1934 Act.
(2) Subsection (1) does not apply to a company that, as a foreign private issuer, satisfies Item 402 of Regulation S-K by providing the information required by Items 6.B "Compensation" and 6.E.2 "Share Ownership" of Form 20-F under the 1934 Act.
ITEM 9 - EFFECTIVE DATE AND TRANSITION
9.1 Effective date
(1) This form comes into force on December 31, 2008.
(2) This form applies to a company in respect of a financial year ending on or after December 31, 2008.
9.2 Transition
(1) The form entitled Form 51-102F6 Statement of Executive Compensation, which came into force on March 30, 2004, as amended,
(a) does not apply to a company in respect of a financial year ending on or after December 31, 2008, and
(b) for greater certainty, applies to a company that is required to prepare and file executive compensation disclosure because
(i) the company is sending an information circular to a securityholder under paragraph 9.1(2)(a) of National Instrument 51-102 Continuous Disclosure Obligations, the information circular includes the disclosure required by Item 8 of Form 51-102F5, and the information circular is in respect of a financial year ending before December 31, 2008, or
(ii) the company is filing an AIF that includes the disclosure required by Item 8 of Form 51-102F5, in accordance with Item 18 of Form 51-102F2, and the AIF is in respect of a financial year ending before December 31, 2008.
(2) A company that is required to prepare and file executive compensation disclosure for a reason set out in paragraph (1)(b) may satisfy that requirement by preparing and filing the disclosure required by this form.